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This thesis describes the development of an systems biology method to study transcriptional pro-
grams that are activated during early and late phases of cell-fusion mediated reprogramming, as
well as an implementation of systems-level analysis using reverse-engineered regulatory networks
to study CNS disorders like Alcohol Addiction, and neurodegenerative disorders like Alzheimer’s
Disease (AD), and Parkinson’s Disease (PD). The results will show an unprecedented view into
the mechanisms underlying complex processes and diseases, and will demonstrate the predictive
power of these methodologies that extended far beyond their original contexts.
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Technological advances that have occurred over the last 20 years have resulted in the generation
and understanding of biological data at an unprecedented scale. The advances have allowed for the
development of systems biology, which has the goal of understanding complex cellular, processes
at the systems level [Lefebvre et al., 2012].
Transcriptional regulation is a vital process in all living organisms, and is a process through
which cells increase or decrease the expression of a gene and its mRNA levels in order to regulate
the activity of the corresponding protein. A very important aspect of the development of systems
biology has been in efforts to reconstruct accurate gene regulatory networks that model this fun-
damental aspect of cellular regulation. The interpretation and interrogation of these networks then
allow for a better understanding developmental, pathological processes, as well as for predicting
cellular responses to external stimuli [Lefebvre et al., 2012].
Many of the computational tools that I have been using throughout my dissertation are based on
the inference and interrogation of gene regulatory networks. These methods support the integrative,
unbiased interrogation of large datasets to study their global behavior rather than studying the effect
of individual genes [Lefebvre et al., 2012]. An important limitation of classical approaches, relying
on statistical association rather than causal regulatory model analysis, is the inability to distinguish
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between primary causal disease drivers and secondary (passenger) non-causal events [Lefebvre
et al., 2010]].
Before I describe the results of my work, I will begin by providing a brief overview of the
methods used to reconstruct regulatory networks and the interrogation of them.
1.1.1 ARACNe and Mutual Information-based Networks
In 2006, the Califano lab developed the Algorithm for the Reconstruction of Accurate Networks
(ARACNe) to accurately predict interactions between transcription factors and their transcriptional
targets [Basso et al., 2005; Margolin et al., 2006].
The method is based on a measure of statistical independence between two variables known as
Mutual Information (MI), a measure that is independent of the linearity of their dependency model.
MI was used to calculate direct, indirect, and non-linear relationships between genes. One major
advantage that MI-based methods have over other linear methods of correlation like Pearson’s or
Spearman’s Correlation is that they are able assess non-linear relationships (Pearson’s correlation)
and non-monotonic (Spearman’s correlation) relationships between genes.
ARACNe, which has been described in much more detail in the original publications [Basso
et al., 2005; Margolin et al., 2006], occurs in 2 major steps. The first step involves estimating the
mutual information for all TF-target pairs and assessing the statistically significant connections by
a bootstrapping step. Next the data processing inequality (DPI) principle is used to prune in the
indirect edges between the TFs and their targets.
The DPI principle is a general principle in information theory that states that information cannot
be increased by some post-processing operation [Cover and Thomas, 1991], and that information
transferred directly is going to be greater or equal to one transferred indirectly. In order for the
information transferred directly to be equal to the one transferred indirectly, the system must be
completely lossless. So for most systems, including biological systems, we can assume that in-
formation transferred directly is always going to be greater than one transferred indirectly. In the
case of our reconstructed network, it states that for any two genes that interact only through a third
gene, the smallest MI value for any of the three possible interactions must come from an indirect
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interaction. This indirect interaction can then be filtered from the network.
Once generated in this way, the networks generated by the ARACNe algorithm are filtered
from a vast majority of false positive interactions, with each TF represented by a “regulon” which
contains a list of genes that are its direct regulatory targets. The predictions of ARACNe have been
the subject of extensive biochemical validation, and are considered to be highly accurate [Zhao
et al., 2009; Repunte-Canonigo et al., 2015; Mani et al., 2008; Della Gatta et al., 2012; Brichta
et al., 2015; Compagno et al., 2009; Carro et al., 2010; Aubry et al., 2015; Lefebvre et al., 2010;
Piovan et al., 2013].
Once the gene regulatory network is constructed, the network can then be interrogated to pre-
dict TFs that are key causal drivers of cellular phenotypes and disorders.
1.1.2 Interrogation of ARACNe networks : MARINa and VIPER
1.1.2.1 Master Regulator Analysis (MARINa)
MARINA or Master Regulator Analysis was one of the first methods developed to interrogate
the gene regulatory networks predicted by ARACNe [Lefebvre et al., 2010]. It was designed to
predict regulators that are sufficient and/or necessary causal determinants of a specific phenotypic
difference, also known as Master Regulators (MRs). MR candidates are identified by MARINa
based on the enrichment of their ARACNe-predicted targets in the differentially expressed genes
of a specific phenotype, similar to using a gene reporter assay approach to detect aberrant activity
of a TF. The difference is that instead of using a single reporter controlled by the promoter of a
TF-target gene, we use the expression of all the ARACNe-inferred targets of the TF. This allows
identification of regulators whose aberrant activity is post-translationally determined, which could
not be identified by differential expression, thus overcoming a fundamental limit of traditional
analysis [Lefebvre et al., 2010]. First, the enrichment of the ARACNe-predicted targets for each
TF in the signature of interest is calculated using gene set enrichment analysis (GSEA) [Jiang
and Gentleman, 2007; Subramanian et al., 2005], with positive and negative regulators of each TF
being considered separately, having been calculated from their spearman correlation in the data
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used to generate the ARACNe network.
The method also corrects for overlapping regulons between bona fide MR-candidates and non-
MR genes by determining whether their enrichment is significantly reduced when overlapping
targets are disregarded in the calculation of the enrichment score. These non-MR genes are defined
as “shadows” of bona fide MR-candidates, and are eliminated from the analysis [Lefebvre et al.,
2010].
Candidate MRs that have significant enrichment scores and are not a shadow of another MR
candidate are selected and sorted by their Differentially Expressed Targets Odds Ratio (DETOR)
[Lefebvre et al., 2010]. The latter represents the density of targets in the leading edge of the GSEA
analysis compared to the remaining range of expression and is a direct measure of the regulatory
impact of the MR. These analyses result in relatively small ranked-lists containing TFs that are
most likely to be responsible for the phenotypic difference in the context of interest [Lefebvre
et al., 2010].
MARINA has also been validated extensively. These methods, for instance, have led to eluci-
dation of experimentally validated drivers of human disease and associated mechanisms, including
the synergistic pair C/EBP and STAT3 in the mesenchymal subtype of glioma [Carro et al., 2010],
the triplet TLX1, TLX3, and RUNX1 in acute lymphoblastic leukemia tumorigenesis [Della Gatta
et al., 2012], the pair FOXM1 and MYB in formation of germinal centers [Lefebvre et al., 2010],
and the AKT1 protein in driving glucocorticoid resistance in T cell acute lymphoblastic leukemia
[Piovan et al., 2013].
1.1.2.2 Virtual Inference of Protein-activity by Enriched Regulon analysis : VIPER
Virtual Inference of Protein-activity by Enriched Regulon analysis, or VIPER, is a more recent
extension of the framework that was first proposed by MARINa [Alvarez, 2013]. In my thesis work,
it was mostly used for the chapter on cell-fusion mediated reprogramming, where VIPER was used
to predict the transcriptional changes that resulted in the human b-cell after cell-cell fusion with
a mouse ES cell. VIPER was chosen over MARINa in this case, provides a statistically sound
framework for the analysis of individual profiles, allowing for a sample-by-sample calculation of
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the TFs activities.
In contrast to MARINa, VIPER calculates the enrichment of each ARACNe-predicted regulon
using analytic rank-based enrichment analysis (aREA). aREA detects shifts in regulon enrichment
by comparing the positions of regulon genes in a rank-sorted gene signature. First the genes with
the greatest changes in expression in the experimental condition are identified based on their abso-
lute change (in a “one-tailed” manner). Next, a similar calculation is done considering the direction
of change (in a “two-tailed” manner), where the “negative” and “positive” regulators are separated
based on their Mode of Regulation (MoR). Finally, VIPER calculates the statistical significance
of the enrichment score of each TF by comparing with a null model that is generated either by
shuffling the samples or genes, depending on the number of samples in the experiment [Alvarez,
2013].
1.1.3 What Lies Ahead
Indeed, as previously shown for the elucidation of human malignancy drivers, the methods devel-
oped by the Califano lab to reverse engineer and interrogate gene regulatory networks approaches
are very effective at identifying both individual and synergistic Master Regulators (MRs) genes
that are both necessary and/or sufficient to induce presentation of a specific pathophysiological
phenotype, while discarding the majority of passenger genes. The following document describes
the application of these methods to a variety of developmental and neurological contexts, in which
the methods proved to be able to elucidate previously unknown mechanisms and drivers of these
phenotypes.
Chapter 2, will describe a project the where regulatory network analysis was combined with
heterokaryon global RNA profiling to examine the transcriptional changes that occur after a human
b-cell has been fused with a mouse ES cell. The results show that major transcriptional changes
that occur in the b-cell are dominated by a bimodal activation of a early and late transcriptional
program, which essentially model a “reversal” of the hematopoietic differential hierarchy.
Chapters 3-5 will describe projects where regulatory network analysis was successfully applied
to the prediction of causal regulators of a complex central nervous system (CNS) disorder (Chapter
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3), and two neurodegenerative disorders : Alzheimer’s Disease (Chapter 4) and Parkinson’s Disease
(Chapter 5). The chapters describe a number of projects that have been published, and more details
can be found in their full manuscripts [Repunte-Canonigo et al., 2015; Aubry et al., 2015; Brichta
et al., 2015].
The results are certainly not a trivial extension of these methods. Neurodegenerative disor-
ders have complex mechanisms that are not always well characterized, and much neuronal activity
occurs away from transcription, at the electrical activity and neurotransmitter-level, which are as-
sociated with rapid changes in the cell. These are all contexts where transcriptional networks are
at a potential disadvantage. A reason for this is because the information-theoretic methods like
ARACNe, MARINa and VIPER were originally developed and validated in contexts that were rel-
atively close to equilibrium, such as cancer cells[Lefebvre et al., 2012]. Extending the methods to
neurological disorders therefore requires a careful characterization of the context being studied. In
addition, behavioral disorders like alcohol addiction can have additional confounding factors in-
cluding individual differences, environmental, social, and developmental factors which may make
it difficult to adequately model the disorder at a transcriptional level. [Koob and Volkow, 2010a].
However, I will show that through the combination of gene regulatory model analysis and a
careful selection of the data and the system being studied, we were able to predict and validate
transcriptional regulators whose activities were significantly associated with the progression of
Alcohol Addiction, Alzheimer’s Disease and Parkinson’s Disease. The concluding chapter will
examine the larger questions that arose from the extension of these methods to more complex
contexts, as well as potential considerations for future projects.
It must also be noted that a number of these projects are based off of papers that have already
been published, and that these projects were the result of the efforts of many collaborators, many
whom I must thank, and without whom I would not have been able to accomplish these projects.
The papers themselves, and much of the introduction and discussion were results that were written
my myself. I attempted to include as much as possible that was written exclusively by myself,
without compromising the “flow” of the papers. However, I realize that I left out many important





Identification of Drivers of Reprogramming
through Cell-Cell Fusion.
2.1 Introduction
Stem cells are defined as clonal cells that have the ability to self-renew and differentiate into more
than one type of specialized cell. Given their unique properties and potential to treat various de-
generative diseases and tissue injury, stem cells have been the subject of intensive research [Han
and Sidhu, 2008]. Pluripotent stem cells can be generated from fully differentiated cells by several
methods, including somatic cell nuclear transfer (SCNT) [Gurdon, 1962], cell-cell fusion with a
pluripotent stem cell [Blau and Baltimore, 1991], or direct reprogramming through the ectopic ex-
pression of a combination of transcription factors Pou5f1, Sox2, Klf4 and c-Myc [Takahashi and
Yamanaka, 2006; Takahashi et al., 2007].
Cell-fusion is a process where two cells are fused to form a multinuclear hybrid. In vitro fusion
of somatic cells with embryonic germ cells or embryonic stem cells has been shown to reprogram
the somatic nucleus to a pluripotent state [Lluis et al., 2008; Tada et al., 1997; Ying et al., 2002;
Sanges et al., 2011; Soza-Ried and Fisher, 2012]. Furthermore, cell fusion may also play a phys-
iological role during in vivo regeneration of several tissues such as liver, brain and retina after
injury [Sanges et al., 2013; Wang et al., 2003; Alvarez-Dolado et al., 2003; Altarche-Xifró et al.,
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2009]. The Wnt pathway is known to play a crucial role in the maintenance of embryonic stem cell
renewal and pluripotency [Hackett and Surani, 2014; Merrill, 2012]. Tcf3 (also known as Tcf7l1),
a transcription factor of the Tcf/Lef family, is an important key effector and acts as a repressor
of the target genes of the Wnt pathway. In embryonic stem cells, Tcf3 has been shown to bind to
the promoters of the genes associated with the core pluripotency network and may act as a critical
regulator of pluripotency and differentiation [Marson et al., 2008; Cole et al., 2008]. The activation
of the Wnt pathway triggers a signaling cascade, which leads to an accumulation of β-catenin in
the cytoplasm and the nucleus. This is followed by a de-repression of Tcf3-bound target genes
resulting in enhancement of embryonic stem cell pluripotency and self-renewal [Yi et al., 2011;
Wray et al., 2011]. Previous work has shown that the fusion of Tcf3 knockout embryonic stem
cells with somatic cells significantly enhances the efficiency of reprogramming of the somatic nu-
cleus to pluripotency [Lluis et al., 2011]. Until now early reprogramming events that are essential
to trigger successful reprogramming are still largely unknown. Therefore the investigation of these
early reprogramming events in the somatic nucleus could provide valuable insights into the key
molecular mechanisms that control the reprogramming of the somatic genome.
Cell hybrids that retain intact nuclei after fusion are also known as heterokaryons. Bi-species
heterokaryons derived from fusion between cells of two different species have been used to study
nuclear reprogramming by monitoring gene expression changes based on species-specific differ-
ences in the genomic sequence [Tsubouchi et al., 2013; Bhutani et al., 2010; Pereira et al., 2008].
A genome-wide expression profile of the hybrids formed between mouse embryonic stem cells and
rat fibroblasts demonstrated the temporal dynamics of mRNA expression in the somatic genome
during reprogramming [Foshay et al., 2012]. Bi-species heterokaryons derived from fusion be-
tween mouse ESCs and human fibroblasts were sequenced for genome-wide expression analyses
to identify genes controlling early events of somatic cell reprogramming after fusion [Brady et al.,
2013].
However a major drawback with such studies is that the interpretation of function relies mainly
on the differential expression levels of genes. An important limitation of these approaches is the
inability to distinguish between causal drivers and non-causal events [Dong et al., 2015; Lefebvre
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et al., 2012]. A regulatory network based approach has been highly successful in elucidating key
genes that are physiological drivers of cancer, neurological disorders, and developmental pheno-
types and have been validated as causally related to phenotype presentation with high probability
(>70%), including the mesenchymal subtype of glioma, acute lymphoblastic leukemia, formation
of germinal centers, as well as a number of neurological disorders, including alcohol addiction,
Alzheimer’s disease and Parkinson’s disease [Zhao et al., 2009; Repunte-Canonigo et al., 2015;
Mani et al., 2008; Della Gatta et al., 2012; Brichta et al., 2015; Compagno et al., 2009; Carro et al.,
2010; Aubry et al., 2015; Lefebvre et al., 2010; Piovan et al., 2013].
For this study we collaborated with the Cosma lab at the Center for Genomic Regulation in
Barcelona. Dr. Karthik Arumugam in the Cosma lab produced heterokaryons representing the fu-
sion of murine murine Tcf3-/- ESCs with human B cells to obtain heterokaryons, which we isolated
at early timepoints after fusion. We performed paired-end RNA sequencing in order to obtain the
global gene expression profile of the heterokaryons at a high resolution. Also, we used a com-
bination of systems biology tools to analyze transcription factor regulatory networks and predict
functional activities of transcription factors that drive the early events during reprogramming of
the somatic cell [Lefebvre et al., 2010; Margolin et al., 2006; Basso et al., 2005]. The analysis
clearly showed that the B cell transcription network was silenced within 4-12 hours after fusion.
However, we were unable to detect the activation of pluripotency-related transcription networks
until 5 days after fusion. Instead we discovered that the majority of the transcription factors active
on day 5 after fusion were associated with hematopoietic stem cell maintenance. Indeed after fu-
sion, we identified two distinct sets of transcription factor regulatory programs: namely “early and
late” programs, which are temporally regulated during the reprogramming of the somatic B-cell. A
correlation analysis of these programs with a human hematopoietic dataset showed that the early
transcription factor program includes master regulators (MRs) belonging to the lineage-committed
hematopoietic progenitors [Laurenti et al., 2013]. This early program is then silenced and is fol-




2.2.1 Generation of Heterokaryon Samples
The Wnt pathway is constitutively active in the Tcf3 -/- ESCs and in vitro fusion of the Tcf3-
/- ESCs with somatic cells leads to a significant increase in the efficiency of the reprogramming
of the somatic cells [Lluis et al., 2008]. To distinguish the transcriptome of the somatic nucleus
from the stem cell nucleus we fused murine Tcf3-/- embryonic stem cells with Epstein Barr Virus
transformed human B -lymphocytes (B-cells) to obtain bi-species heterokaryons. To identify novel
master regulators that drive somatic nuclear reprogramming we analyzed the transcriptional pro-
file of the somatic nucleus at early time-points after fusion. The ESCs and the B cells were labeled
with red and green lipophilic fluorochrome dyes (DiD and DiO), respectively. The stained cells
were then fused in vitro using polyethylene glycol (PEG) and the hybrid cells were FACS sorted
at different time-points after fusion 2.1. The isolated heterokaryons were then processed for RNA
extraction. This work was done in collaboration with the Cosma-Lab at the CRG, with the experi-
mental work performed by Dr. Karthik Arumugam.
2.2.2 Sequencing and Correction
We performed paired-end RNA sequencing in order to obtain the global gene expression pro-
files of the heterokaryons at a high resolution. The sequencing was performed at a depth of up to
100M paired-end reads, and the reads were aligned to the latest human (hg19) and mouse (mm10)
genomes using TopHat (v2.0.4) [Trapnell et al., 2009a]. Since the reads were obtained from both
the murine and human nucleus of the heterokaryons, the mapping was done with higher stringency
settings. Reads were only counted if both paired-end reads were mapped to the same gene, and
were in the correct orientation. Table 1 shows the number of reads that mapped to either the human
(hg19) or mouse (mm10) genomes.
The mapped reads were observed to have a bias toward the mouse genome, with the bias in-
creasing until the 5-day timepoint. Around 2% of the total reads were multi-mapping, meaning
they mapped to regions in both genomes. These were handled using a “fair-split” method that
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assigned each multi-mapping read to either the human or mouse genome by considering the gene-
boundaries, mapping scores and gene expression. A more detailed description of the “fair-split”
method can be found in the Methods section. Tables 2.2-2.4 shows the number of reads that mapped
to the mouse and human genomes after the multi-mapping reads were re-mapped.
2.2.3 Data Quality Control
We observed significant reproducibility between replicates, with Spearman correlation values >
0.95 for all comparisons, as seen in Figure 2. At 5 days after fusion, the mRNA expression of
human pluripotency markers such as NANOG, POU5F1 and KLF4 were upregulated in the het-
erokaryons compared to the unfused human B-cell. This confirmed that cell-fusion with the murine
Tcf3-/- ES cells had indeed induced the expression of mRNA transcripts of the pluripotency mark-
ers (Figure 2.3) and is consistent with a previous report [Pereira and Fisher, 2009]. Hierarchical
clustering (Figure 2.4) of the global gene expression levels showed that almost all the sample
replicates separated according to their respective timepoints after cell fusion.
Differential expression analyses of the human transcriptome showed that significant changes
in gene expression occur globally in the human genome after cell fusion (Figure 2.5). Interest-
ingly a similar analysis of the mouse transcriptome showed that very few genes were differen-
tially expressed between the different timepoints in the heterokaryons (Figure 2.6). This confirms
that the murine embryonic stem cell nucleus is dominant in the fused heterokaryons and signif-
icantly influences the transcriptional activity of the human somatic cell nucleus. This is consis-
tent with previous studies that reported a dominant nature of the embryonic stem cell in the tran-
scriptional regulation of fused ES-somatic cell hybrids [Pereira et al., 2008; Cowan et al., 2005;
Foshay et al., 2012]. Taken together, expression level analysis of the heterokaryons showed high
quality data for both the human and mouse transcriptome, and determined that the data could con-
fidently be used for regulatory network analysis.
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2.2.4 Regulatory Network Analysis of Heterokaryon Data using Virtual In-
ference of Protein-activity by Enriched Regulon (VIPER)
For our analysis we used a human B-cell regulatory network (BCRN) that was reverse engineered
using the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) [Basso
et al., 2005; Margolin et al., 2006]. ARACNe is an information-theoretic approach for the inference
of the targets of transcription factors, and maps causal relationships between target genes and their
upstream transcriptional regulators [Margolin et al., 2006]. The BCRN used in this study was an
integration of two previously published datasets, and was originally generated from a combination
of naı̈ve and germinal-center human B-cells, human b-cell lymphomas and cell lines [Basso et al.,
2005; Lefebvre et al., 2010]. The BCRN has been extensively validated in its ability to identify
MYB and FOXM1 as master regulators of proliferation in the germinal center (GC) [Lefebvre
et al., 2010]. In order to determine whether the b-cell regulatory network was indeed the most
suited for predicting the activities of transcription factors that are associated with reprogramming, a
comparison was made to mouse embryonic and epiblast stem-cell regulatory networks. The results
of the analysis showed that the BCRN was indeed able to best-predict the transcriptional changes
occurring in the heterokaryons, when compared to the mouse EpiSC and ES regulatory networks.
The details of the analysis can be found in supplementary data.
The function of many transcription factors is regulated post-transcriptionally and therefore their
activity is not always directly proportional to their expression levels. The Virtual Inference of
Protein-activity by Enriched Regulon (VIPER) algorithm [Alvarez, 2013], along with the related
Master Regulator Inference Algorithm (MARINa) [Lefebvre et al., 2010], assess the activity of
a transcription factor by computing the differential expression of its targets, which are given by
the regulon. By doing so, key drivers, also known as “Master Regulators”, are chosen in an un-
biased manner, and represent transcription factors whose activities are most causally related to
the global changes in gene expression. These regulatory network based analyses are able to iden-
tify potential master regulator (MR) genes whose activities are both necessary and/or sufficient to
induce presentation of a specific phenotype, while discarding a majority of the passenger genes
[Lefebvre et al., 2010]. This methodology has been highly successful in elucidating key biolog-
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ical drivers of cancer, neurological disorders, and developmental phenotypes [Zhao et al., 2009;
Repunte-Canonigo et al., 2015; Mani et al., 2008; Della Gatta et al., 2012; Brichta et al., 2015;
Compagno et al., 2009; Carro et al., 2010; Aubry et al., 2015; Lefebvre et al., 2010; Piovan et al.,
2013].
In order to predict the activities of transcription factors that are associated with reprogramming,
the BCRN interactome was interrogated using the Virtual Inference of Protein-activity by Enriched
Regulon (VIPER) algorithm [Alvarez, 2013]. VIPER takes the ARACNE-predicted targets of each
transcription factor in the BCRN interactome and computes their differential expression, while also
considering regulator mode of action, regulator-target gene interaction confidence and pleiotropic
nature of target-gene regulation[Alvarez, 2013]. The application of VIPER on the heterokaryon
signatures allowed us to predict the activities of the transcription factors that were associated with
early events following cell fusion, on a sample-by-sample basis. A VIPER analysis was performed
by comparing the expression of each heterokaryon sample with the average expression of the un-
fused b-cell samples as the control. As a result we obtained the predicted activity values of 633
transcription factors that were significant in at least one sample with an FDR < 0.01 (Figure 2.7,
Table 2.5).
2.2.5 Singular Value Decomposition (SVD) Results: Heterokaryons
We wanted to further investigate if we can isolate transcription factors that have a specific temporal
pattern of activities that could provide us more insight into the physiological mechanism of the
events during cell-fusion mediated reprogramming.
Singular value decomposition (SVD) is a method in linear algebra that allows for a factorization
of any m x n matrix into the following form:
Amn = UmmSmnVnn
T (2.1)
When applied to gene expression data, the method can be used to bring out dominant under-
lying behaviors in gene expression patterns. The seminal paper by Alter et al. in 2000 was one
of the first applications of the method for gene expression data [Alter et al., 2000]. According to
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this study, SVD factorization of the gene expression data resulted in a transformation of the data
from an N-genes and M-arrays space in to an M-“eigenarrays” and “M-eigengenes” space, which
accounted for most of the variance, despite the great reduction in dimensionality. The proportion








Since then, SVD has been used in a variety of applications, in particular as a multivariate di-
mension reduction technique in the identification of gene expression quantitative trait loci (eQTL)
[Biswas et al., 2008]. Even outside field of genome-wide expression modeling, SVD has shown
particular strengths in resolving signals from time-course data, splitting it into its time-independent
and time-dependent components [Rajagopal et al., 2004].
In the case of transcriptional regulatory network analysis, we surmised that SVD would shed
light on the important transcriptional programs that are temporally regulated during reprogram-
ming. Applying the SVD technique to the VIPER-predicted activity matrix allowed us to reduce
the dimensionality of the results and estimate the contribution of each transcription factor’s activity
to the dominant transcriptional program.
SVD analysis reduced the dimensionality of the VIPER matrix, which originally contained
the predicted activity of 633 TFs across 12 heterokaryon samples, to 12 eigengenes, where each
eigengene was a linear combination of the predicted activity of each TF, weighted by a coefficient
that was proportional to their contribution to the transcriptional program.
Based on the proportion of variance explained by each of the 12 eigengenes, we observed that
the first two eigengenes accounted for almost 85% of the total variance (Figure 2.8). When the
feature levels of the eigengene 1 and eigengene 2 were plotted for all the heterokaryon samples,
each eigengene showed a unique time-dependent bimodal pattern of transcription factor activities
during the heterokaryon reprogramming (Figure 2.9).
Based on the eigengenes 1 and 2 we can broadly classify the transcription factors into 2 distinct
clusters - “early” and “late”. TFs that contributed significantly to each cluster were considered to be
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ones who had coefficients in the top-5% when compared to random. As a result, we found an early
cluster of 105 transcription factors were significantly associated with eigengene1. These TFs were
active at 4 hours and 12 hours after cell fusion but are silenced at later timepoints. Conversely, we
also found a late cluster of 65 transcription factors that are significantly associated with eigengen2.
These were silent during the early timepoints but are activated at later timepoints at 48 hours and
120 hours after cell fusion. The identity and NES values for these two sets of TFs can be found
in Table 2.6 and Table 2.7. The results clearly indicate that there are 2 distinct programs that are
implicated in the dominant transcriptional changes that occur during reprogramming of the somatic
human genome after cell fusion.
2.2.6 Differentiation and Reprogramming Markers
We verified the activity of the B-cell related transcription factors (BATF, BATF2, BATF3, TEAD1,
EGR1, FOXP1) that are known to maintain B cell commitment and differentiation [Dinkel et al.,
1998; Laurenti et al., 2013], B-cell activation [Betz et al., 2010; Ise et al., 2011] and B-cell survival
[van Keimpema et al., 2014]. We found that both expression and activity of all B-cell related
transcription factors was decreased in activity and expression at the 4-hour timepoint after cell-cell
fusion (Figure 2.10A and Figure 2.10B). This suggests that the transcription network associated
with the B- cell identity is indeed silenced after cell fusion.
We went on to look for the reactivation of a series of pluripotency markers to confirm if the
somatic genome had been reprogrammed to pluripotency. We analyzed the differential expres-
sion and the VIPER predicted activities of these marker genes across all the timepoints in the hu-
man genome after cell fusion. The mRNA expression levels of some of the pluripotency markers
POU5F1, NANOG and SALL4 were indeed upregulated as noted earlier (Figure 2.3, Figure 2.10C
and 2.10D) in a step-wise manner. However, with the exception of Klf4, the VIPER activities of the
pluripotency genes remained silenced until 5 days after fusion. This indicates that although these
pluripotency markers are upregulated at the mRNA level they may not be functionally relevant.
We did not detect any changes in the mRNA expression of Myc, however the VIPER activity was
high at the early times and was silenced later. This suggests that the heterokaryons are undergoing
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a proliferative phase specifically at the early stages of reprogramming.
We performed some literature mining for some of the transcription factors that were identified
by VIPER with significant activities at 5 days after cell fusion. Interestingly, transcription fac-
tors such as ASH1L, DMTF1 and LYL1 that were activated on day 5 are known to play a role in
hematopoiesis and hematopoietic stem cell maintenance (Jones et al., 2015; Kobayashi and Srour,
2011; Souroullas et al., 2009). These factors were among the most up-regulated in their transcrip-
tion factor activity at day 5 (Figure 10E and Figure 10F).
We performed some literature mining for some of the transcription factors that were identified
by VIPER with significant activities at 5 days after cell fusion. Interestingly, transcription fac-
tors such as ASH1L, DMTF1 and LYL1 that were activated on day 5 are known to play a role
in hematopoiesis and hematopoietic stem cell maintenance [Jones et al., 2015a; Kobayashi and
Srour, 2011; Souroullas et al., 2009]. These factors were among the most up-regulated in their
transcription factor activity at day 5 (Figure 2.10E and Figure 2.10F).
These results lead us to postulate that upon fusion with the Tcf3-/- mouse ESC the human B
cell program is silenced and is potentially reprogrammed to a hematopoietic stem cell-like state.
To determine the phenotypic identity of the human genome within the heterokaryon we compared
the heterokaryons with a publicly available hematopoietic stem cell dataset.
2.2.7 HSC Reference Dataset
In a recent study, genome-wide expression analyses was performed on all the populations of stem
cells and differentiated progenitor populations of the human hematopoietic hierarchy (Figure 2.11)
[Doulatov et al., 2010]. The samples consisted of a population of quiescent hematopoietic stem
cells (HSC), which are multi-potent stem cells that can differentiate into all blood cell types of the
hematopoietic lineage [Doulatov et al., 2010]. The HSCs after exiting quiescence form proliferat-
ing multipotent progenitor (MPP) cells can differentiate into committed progenitors of the myeloid
and the lymphoid lineages [Notta et al., 2011]. In the lymphoid branch, the multi-lymphoid pro-
genitors (MLP) can differentiate into T lymphocytes and precursors of B lymphocytes and natural
killer cell (B-NK) [Doulatov et al., 2010]. However, previous studies have shown that the MLPs
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are not entirely committed to the lymphoid lineage and can also differentiate into monocytes from
the myeloid lineage [Doulatov et al., 2010]. It has also been shown that the genome-wide mRNA
expression profile of the MLP population is highly similar to the stem cell populations of HSCs
and MPPs [Laurenti et al., 2013]. Therefore the human MLPs are physiologically closer to the
hematopoietic stem cell in their potential to differentiate into the myeloid and lymphoid lineage,
with a bias towards the lymphoid lineage. A lymphoid primed multipotent progenitor (LMPP) pop-
ulation was also previously identified in the murine hematopoietic system with the ability to differ-
entiate into the lymphoid lineage and the monocytes in the myeloid lineage [Adolfsson et al., 2001;
Adolfsson et al., 2005]. Therefore the physiological state of the lymphoid biased progenitor popu-
lations is conserved in mice and human. In the myeloid branch, the common myeloid progenitors
(CMP) are fully committed to the myeloid lineage and can differentiate into the myeloid progeni-
tors of granulocytes and monocytes (GMP) and megakaryocytes and erythrocytes (MEP).
2.2.8 Hierarchical Clustering and VIPER on HSC dataset
Before applying regulatory network analysis to the reference dataset, we first sought to assess the
quality and consistency of the samples. Since the cells were obtained from human cord blood, we
expected some variation from sample to sample at the expression level.
We performed hierarchical clustering on all the HSC samples together based on the global
gene expression (Figure 2.12). A number of samples were showing significant variations between
samples of the same cell type. We observed two large clusters, with the stem-like cells (HSCs,
MPPs and MLPs) clustering together on one side, and the more lineage-committed cells like CMPs,
GMPs and MEPs clustered on the other side. However a number of cell types, including GMP,
ProB and BNK samples showed more variation in clustering. This could be due to the variations
between individual cord blood donors and the intrinsic heterogeneity of the cell populations.
We reasoned that the clustering based on mRNA expression profile is perhaps more sensitive
to sample variations. This could be resolved by a robust VIPER-estimated activity for transcrip-
tion factors that may regulate the cell state. In addition, VIPER also has the ability to calculate
transcription factor activity on a sample-by-sample basis and allows for the prediction of outliers.
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Therefore, VIPER was run using the average expression of each HSC sample and the unfused
b-cell samples as the control. As a result we obtained the predicted activity values of 445 tran-
scription factors that were significant in at least one sample with an FDR < 0.01 (Figure 2.13).
Interestingly, the heatmap of the VIPER activities in the HSC dataset showed a bimodal pattern
reminiscent of the early and late transcription program in the heterokaryons (Figure 2.9). The
maintenance of the stem cell population is regulated by a distinct cluster of “stem-like” transcrip-
tion factors (Figure 2.13). The “stem-like” transcription factors are silenced upon differentiation
to more committed progenitors of the myeloid lineage. We also observed that “stem-like” clus-
ter of transcription factors showed similar activity in the MLPs and the stem cell populations of
HSC and MPP. This is consistent with the previously reported observation that the MLPs are more
stem-like progenitors and have a transcriptional profile similar to the stem cell populations of HSCs
and MPPs. Upon differentiation, the committed populations are then controlled by another unique
cluster of “progenitor-like” transcription factors (Figure 2.13) which were otherwise silent in the
stem cell populations. However, the ProB and B-NK precursors continued to show significant vari-
ations across the samples. Overall they showed a profile that had similarities in both the stem cell
population and the progenitor which is consistent with the published report [Laurenti et al., 2013].
2.2.9 Comparison to Heterokaryon Results (Fisher’s Exact Test)
We further wanted to investigate if the bimodal activity of the 2 clusters of transcription factors
in the hematopoietic stem cell dataset had any similarity to the early and late transcription pro-
grams identified in the heterokaryon dataset (Figure 2.9). Using Fisher’s Exact Test we estimated
the overlap between the two datasets for the transcription factors that had a significant VIPER
activity (FDR < 0.05) and had positive enrichment scores in both the datasets (Figure 2.14). The
similarity test showed that the heterokaryon samples from early time points (4h and 12h after
fusion) were overlapped significantly with the lineage-committed progenitor populations, which
mainly consists of the myeloid progenitors (GMP, MEP, CMP). However, the late time points of
the heterokaryon samples (48h and 120h after fusion) overlapped significantly with the stem and
multipotent-progenitor like populations (HSC, MPP, MLPs). The heterokaryons at 5 days post-
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fusion also showed a significant overlap with the ProB samples. This is consistent with the obser-
vation that the ProB samples in the HSC dataset have clusters of transcription factors that have
activities similar to the HSC, MPP and MLP samples as shown previously (Figure 2.13).
We then isolated the transcription factors that were significant (FDR < 0.01) in their activities
in both the HSC and heterokaryon VIPER results (Figure 2.18).
There were 16 genes that had similar VIPER activity at the early time points in the het-
erokaryons and the lineage committed myeloid progenitors in the HSC dataset (Figure 2.15). There
were 26 genes that showed similar VIPER activity at the late time points and the multipotent stem
and progenitor samples (Figure 2.16). Both sets of genes were common to the set of TFs that were
significantly associated with eigengenes 1 and 2 (Table 2.6 and Table 2.7), indicating they were
part of the dominant transcriptional program.
Hematopoietic stem cells (HSC) are quiescent and are capable of long-term repopulation of
the bone-marrow. During differentiation, the HSC exits quiescence to form the lineage-committed
progenitors that are actively proliferating. Interestingly, the transcription factors such as FOXM1,
MYBL2, E2F8 AND PTTG1 that are active in the heterokaryon during the early time points are
mainly associated with cell cycle and cell proliferation [Kalin et al., 2011; Lammens et al., 2009;
Martinez and DiMaio, 2011; Vlotides et al., 2007].
The similarity of the activity of these genes with the lineage-committed progenitor cells in the
HSC dataset, suggests that the human B cell in the heterokaryon is reprogrammed to proliferative
progenitors at the early time points. Curiously, FOXM1 [Hou et al., 2015] and MYBL2 (b-myb)
[Baker et al., 2014] have also been shown to be associated hematopoietic stem and progenitor
maintenance.On the other hand, the transcription factors such as DMTF1, ASH1L and FLI1 that are
active at the late timepoints in the heterokaryons have also been identified as master regulators of
hematopoietic stem and progenitor maintenance [Jones et al., 2015b; Kobayashi and Srour, 2011;
Schütte et al., 2016].
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2.2.10 Experimental Validation of the MRs controlling reprogramming
As discussed above we identified that the B cell nucleus in the heterokaryons is reprogrammed
in a biphasic manner with an initial lineage committed progenitor-like state followed by a late
hematopoietic stem/progenitor-like state. Based on our computational analyses, we have identified
2 sets of genes as potential master regulators that could induce this biphasic reprogramming of
the heterokaryon. In order to determine the physiological role of these predicted master regulators,
we chose to investigate the 2 sets of genes separately by designing experiments that best explain
their phenotype. The first set of early genes were identified as potential candidates that induce
the reprogramming of the human B lymphocytes to a committed myeloid or lymphoid progenitor
like state. The second set of late genes were identified as potential master regulators that control
the reprogramming from the lineage committed progenitor state to a hematopoietic stem/progenitor
like state. For this part of the project we collaborated with the Cosma lab at the Center for Genomic
Regulation in Barcelona. Dr. Karthik Arumugam in the Cosma lab has performed the following
experiments.
2.2.11 Validation of genes that may control the reprogramming of B cells to
lineage-committed progenitors
To determine the role of early genes we will over express them in primary human B lymphocytes
isolated from the peripheral blood or cord blood of human donors. However, human B lympho-
cytes are highly resistant to lentiviral or retroviral infection which are the conventional means of
delivering ectopic expression plasmids. To circumvent this problem, we will use Sendai viruses as
delivery vehicles for expressing the genes in the B cells [Bueno et al., 2015]. The cells will then
be validated for reprogramming into lineage-committed progenitors using the following assays -
Flow cytometry – The human B lymphocytes are marked by the surface markers CD19 and
CD20 . FACS analysis will allow us to determine reprogramming by tracking the loss of these
markers in B-cells[Laurenti et al., 2013]. In addition we will also verify the appearance of the
CD34 surface marker that marks the majority of the human hematopoietic progenitors. Further
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within the CD34 positive population we will also verify the presence of specific markers for the
lymphoid and myeloid lineages [Laurenti et al., 2013].
In vitro colony formation assays – Hematopoietic stem and progenitor cells can be differenti-
ated to form colonies of hematopoietic cells of different lineages upon stimulation with a cocktail
of cytokines in a semisolid media made of methylcellulose [Wognum et al., 2013]. Reprogrammed
human B lymphocytes will be plated in meythlycellulose media to verify their ability to differenti-
ate into cells of different lineages.
In vivo short-term engraftment assays – Lineage committed progenitors can also be differ-
entiated in vivo in the bone marrow of severely immuno-compromised transgenic mice NOD.Cg-
Prkdcscid Il2rgtm1Wjl / SzJ or also known as NSG mice [Mazurier et al., 2003]. The lineage-committed
progenitors can engraft in the bone marrow of the NSG mice for a short period of two weeks dur-
ing which their differentiation into more committed cell types can be monitored. Reprogrammed
human b lymphocytes will be transplanted directly in the bone marrow by injecting the cells into
the femur of the NSG mice. The mice will be sacrificed two weeks after the transplantation and the
femur samples will be collected and analyzed by FACS for expression of lineage-specific surface
markers.
2.2.12 Validation of genes that may control the reprogramming of lineage-
committed progenitors to HSC/MPP/MLP like state
To determine the role of Set 2 genes we will overexpress them in CD34+CD38+ myeloid lineage-
committed progenitor population isolated from human cord blood [Doulatov et al., 2010]. The
cDNAs for the candidate genes will be cloned into an inducible lentiviral vector [Meerbrey et al.,
2011]. We will employ a FACS sorting method to isolate the CD34+CD38+ population from hu-
man umbilical cord blood samples. The genes will be induced for over-expression and then vali-
dated by differentiation assays to confirm the physiological phenotype of the reprogrammed cells.
Flow cytometry Analyses – The reprogrammed cells will be analyzed by FACS for the HSC/MPP/MLP
compartment which is generally marked by the surface marker combination of CD34+CD38-
[Doulatov et al., 2010]. We will also analyze additional surface markers such as CD45RA and
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CD90 in combination with the CD34 and CD38 surface markers to resolve the HSC, MPP and
MLP populations [Laurenti et al., 2013].
Long-Term Culture Initiating Cell Assay (LTC-IC) – Hematopoietic stem cells are marked
by 2 physiological characteristics- multipotency and quiescence. The multipotent characteristic al-
lows the HSCs to differentiate into all cell types of the myeloid and lymphoid lineage. On the other
hand, the quiescence is a unique feature of the HSC population that allows self-renewal through
the entire life span of an individual. This physiological feature can be validated through an in vitro
assay known as the Long-Term Culture Initiating Cell Assay or LTC-IC [Liu et al., 2013]. Here
the hematopoietic stem cells are plated on a specific bone marrow feeder layer, which induces
the differentiation of the HSCs. The cells are cultured for more than 5 weeks and then there are
transferred to semisolid methylcellulose plates. During this period the lineage-committed progen-
itors exhaust themselves by proliferating rapidly. After further 2 weeks of prolonged culture the
hematopoietic stem cells can form colonies whereas majority of the lineage-committed progenitors
are unable to form colonies.
Lineage committed progenitors can also be differentiated in vivo in the bone marrow of severely
immuno-compromised transgenic mice NOD.Cg-Prkdcŝcid Il2rgt̂m1Wjl / SzJ or also known as
NSG mice [Mazurier et al., 2003].
In vivo short-term engraftment assays – Hematopoietic stem cells can be differentiated in
vivo in the bone marrow of severely immuno-compromised transgenic mice NOD.Cg-Prkdcscid
Il2rgtm1Wjl / SzJ[Mazurier et al., 2003]. Further hematopoietic stem cells can engraft for a long
period in the NSG mice from 8 to 24 weeks during which their differentiation into more committed
cell types can be monitored. Reprogrammed human CD34+ cells will be transplanted into the
femur of the NSG mice. 8 weeks after injection the mice will be sacrificed and the bone marrow
and peripheral blood samples will be analyzed by FACS for expression of lineage-specific surface
markers. We will also analyze the presence chimerism of the human HSC compartment in the bone
marrow of the transgenic mice.
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2.3 Discussion
In this project, we fused murine ES cells with human B cells to obtain bi-species heterokaryon
cells and performed global transcriptional profiling to obtain gene expression profiles at early time-
points after PEG induced cell-fusion. We then performed a transcription factor regulatory network
analysis that allowed us to predict the functional activities of transcription factors. As a result we
identified two dominant transcriptional programs that were activated during early and late phases
of cell-fusion mediated reprogramming. Our work is one of the first demonstrations of combining
these methods in the study of cell-fusion mediated reprogramming, and offers an unprecedented
view of the early events following cell-fusion.
The regulatory network-based approaches allowed for us to overcome a limit of traditional
studies which typically examine reprogramming in heterokaryons through either the expression of
a few select markers, or through differential expression analysis. The methods allowed us to iden-
tify the potential causal drivers of the reprogramming process in an unbiased manner based on their
activity, rather than changes in expression (Figure 2.17, Figure 2.18). In contrast to the highly sig-
nificant VIPER-predicted activities for these MR candidates, many factors showed non-significant
changes in their expression (the majority having less than 2-fold change in expression), meaning
differential expression alone would not have facilitated the identification of these factors. Further
this approach allowed us to discover a possible novel mechanism of reprogramming of somatic
cells after cell fusion. We found that 5 days after fusion the B cells were not yet reprogrammed to
an embryonic stem cell-like state. Instead we observed that the human B cells were reprogrammed
to it’s parental hematopoietic stem cell-like state. This reprogramming occurred in two distinct
phases that were temporally regulated by two distinct clusters – driven by what we called “early”
and “late” transcription factors.
Upon comparison of the transcriptional landscape of the heterokaryons to a reference HSC
dataset we found that the early transcription factors regulating the B cells in the heterokaryon were
similar to the proliferative lineage-committed progenitors (Figure 19). The early transcription fac-
tors are then silenced and replaced by late transcription factors in the B cell nucleus which is
similar to the hematopoietic stem cells in the HSC dataset (Figure 2.19). In this project, we have
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only measured the B cell mRNA expression up to 5 days after fusion, which limits our ability to
identify the final state of the reprogrammed B cell. Therefore it is possible that at the later time
points the B cell is further reprogrammed to a pluripotent embryonic stem-cell like state. How-
ever at 5 days after fusion, our computational analysis suggests a “reversing” of the B cell on the
hematopoietic differentiation hierarchy, which occurs in a bimodal manner during the early steps
of reprogramming. The current experimental validation strategy is designed to test this hypothesis,
and we plan to conduct it in two steps. The first step is designed to test for reprogramming of b-cells
into lineage committed progenitors, and the second step designed to screen for the transformation
of the lineage committed progenitors into a HSC-like state. The validation of the MR candidates
would allow for a much more complete understanding of the mechanisms underlying process.
Currently, the allogeneic transplantation of HLA-matched HSCs are among the most widely
used cellular therapies, but are also frequently associated with graft rejection [Lee et al., 2015]. In
addition, one challenge that has been facing the HSC field has been the lack of appropriate con-
ditions to maintain HSCs in vitro [Lee et al., 2015]. Therefore, attempts have been made to gen-
erate HSCs by differentiating pluripotent human embryonic stem cells to hematopoietic progeni-
tors, or by reprogramming murine peripheral blood cells to HSC-like cells [Doulatov et al., 2013;
Riddell et al., 2014]. These methodologies could serve as a valuable tool for generating HSCs to
allow for safer autologous transplantation therapies. The current study of the heterokaryons with
the combination of global gene expression profiling of early post cell-fusion events, and a regu-
latory network analysis has helped us discover novel transcriptional mechanisms underlying the
reprogramming of human somatic B cell into multipotent HSCs. If validated experimentally, the
results would be one of the first demonstrations of the reprogramming of human B-cells into HSCs




The B-cell regulatory network (BCRN) used in this study was an integration of two previously
published datasets. The first human BCRN was reverse engineered by the ARACNe algorithm
from a dataset of 264 gene expression profiles that included normal (naive and germinal-center
B-cells), several tumor phenotypes including, B-cell lymphomas and cell lines. Gene expression
was profiled on Affymetrix U133 Plus 2.0 arrays, processed by the Cleaner algorithm [Alvarez
et al., 2009], and normalized with MAS5 [Affymetrix, 2002]. The resulting BRCN and contained
predictions for 1,223 transcription factors regulating 13,007 target genes through 327,837 interac-
tions. The second human BCRN was built from an additional set of 254 samples including normal
cells, several tumor phenotypes and cell lines. Gene expression for this dataset was profiled on
Affymetrix HGU.95.Av2 arrays, and also went through processing through MAS5 [Affymetrix,
2002], Cleaner[Alvarez et al., 2009] and ARACNe [Margolin et al., 2006]. This second regula-
tory network included 173,539 predicted interactions between 633 transcription factors and 6,403
genes. The integration was done by taking a union of the predictions of the two networks, with
TF-target interactions that were predicted by both networks having their p-values integrated us-
ing Fisher’s method [Fisher, 1925]. The final BCRN contained predictions for 1,241 transcription
factors regulating 11,770 target genes through 288,616 interactions.
2.4.2 VIPER
The relative activity of each transcription factor represented in the BCRN was inferred using the
VIPER algorithm, available as a package through Bioconductor [Alvarez, 2013]. Conceptually, the
VIPER algorithm is similar to the Master Regulator Inference Algorithm (MARINA) [Lefebvre
et al., 2010], which uses the TF targets inferred by the ARACNe algorithm to predict drivers of
changes in cellular phenotypes. In addition to calculating the enrichment of ARACNe-predicted
targets in the signature of interest, VIPER also takes into account the regulator mode of action,
regulator-target gene interaction confidence and pleiotropic nature of each target gene regulation.
26
Statistical significance, including P value and normalized enrichment score (NES), was estimated
by comparison to a null model generated by permuting the samples uniformly at random 1,000
times.
2.4.3 Transcription Factors Classification for Network
To identify transcription factors (TFs), we selected the mouse genes annotated as “transcription
factor activity” in Gene Ontology and the list of TFs from TRANSFAC [Wingender et al., 2000].
This produced a final list of 1,794 TFs, which mapped to 3,758 probesets on the gcrma-normalized
expression profile [Wu et al., 2004].
2.4.4 HSC Dataset
The HSC dataset used in our analysis was a previously published dataset (GSE42414) that was
generated from human HSCs and progenitor cell populations that were isolated from human cord
blood [Laurenti et al., 2013]. The authors obtained RNA from flow-sorted populations of human
cord blood based on surface expression levels of CD34, CD38, CD45RA, Thy1 and CD49f, CD10,
CD7, CD19 and CD1a. Samples were profiled using the Illumina HumanHT-12 WG-DASL v
4.0 R2 expression beadchip [Laurenti et al., 2013]. The reference dataset was publicly available
through the Gene Expression Omnibus (GSE42414).
2.4.5 Transformation for HSC and Heterokaryon dataset for VIPER analy-
sis.
Since the HSC dataset was profiled on a microarray platform and the heterokaryon samples were
profiled using RNA-seq, the datasets were not directly comparable. The differences between RNA-
seq and microarray data arise from the fact that microarray data is treated as a continuous mea-
surement of the fluorescence intensity, typically modeled by a log-normal distribution. RNA-seq
experiments count the number of reads that map to a particular gene or transcript, and methods
that analyze RNA-seq data commonly use a Negative Binomial (NB) distribution [Soneson and
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Delorenzi, 2013]. In order to make the two datasets comparable, both expression profiles were
transformed using rank and z-transformation. More specifically, the gene expression was rank-
transformed for each sample, and then each gene was z-transformed across samples. The two gene
expression profiles were combined after this transformation.
2.4.6 Mapping to Human and Mouse Genome and Multi-mapping reads
Samples were analyzed on an Illumina HiSeq 2000 sequencer using 100 bp paired-end sequencing.
RNA-Seq reads were first mapped to the Mus musculus assembly 10 reference genome (mm10),
and the human assembly 19 (hg19) reference genome using Tophat (v 2.0.4) [Trapnell et al.,
2009b]. Reads mapping to known genes, based on Entrez gene identifiers, were then counted using
the GenomicFeatures R-system package (Bioconductor) [Lawrence et al., 2013].
Multi-mapping reads are a challenge that we faced when sequencing from heterokaryons, since
reads would come either from the ES Mouse nucleus or the Human B-cell nucleus. The reads would
be about 5% of the total reads sequenced, but would typically be concentrated in highly-conserved
and functionally important genes. Some groups have run into the same problem choose to eliminate
the reads, and it was said that the choice didn’t have a significant effect on them. In the abundance
of caution, we attempted to include the reads into the count files into the final counts.
The first step that was taken attempted to by increasing the stringency of the mapping, both
made possible by the paired-end sequencing. More specifically, the “no–mixed” flag in TopHat as-
sured that alignments where both reads in the pair were mapped were included. The “no–discordant”
flag assured that only concordant reads were mapped, meaning the reads had the expected mate
orientation and expected distance between them.
Once the reads were mapped, the read names given by the Illumina Sequencer were used to sep-
arate the reads that mapped uniquely to each genome to multi-mapping reads that mapped to both
genomes. First the counts were summarized using the GenomicRanges package on bioconductor
[Lawrence et al., 2013].
Next we reasoned that the multi-mapping reads would fall into one of 3 situations. In the first
situation, the reads would map to both the mouse and human genomes, but would only map to
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a gene in one of genomes. In this case the reads was assigned to the appropriate gene. Next, we
reasoned that a read would map, so we used the CIGAR field, which is a feature of the SAM file
and gives a representation of how the read mapped to the reference genome, and whether there
was a match/mismatch, insertion, deletion, or if any positions were skipped. We used to CIGAR
score to determine which genome a read mapped to, and if there was a difference, then the read
was assigned to the genome with the higher quality read.
Finally we considered reads that mapped perfectly to genes in both genomes. For these we
chose to “fairly split” the reads between each of the genomes by considering how many unique
reads had already been mapped to each gene. We reasoned, that the multi-mapped reads would
follow the same overall proportion of expression that would already be modeled by the unique
reads, which would be affected by differences in gene length, expression levels, or a combination
of both. For example, if a read had been assigned to a mouse gene that already had 15 unique reads
mapped to it, and a human gene that already had 3 unique reads mapped to it, then the mouse gene
would receive 15/18th of the read and the human gene would receive 3/18 of the read. The final
counts were later rounded to the nearest integer value.
2.5 Supplementary Information
2.5.1 Performance analysis of B-cell regulatory network, Murine ES and
EpiSC regulatory networks
In order to determine which regulatory model would best represent the early events associated with
cell-fusion mediated reprogramming, we compared the results of three regulatory networks that
were generated using human b-cells, mouse embryonic stem cells, and mouse epiblast stem cells.
All three regulatory networks were reverse engineered using the Algorithm for the Reconstruction
of Accurate Cellular Networks (ARACNe) [Margolin et al., 2006]. ARACNe is an information-
theoretic approach for the inference of the targets of transcription factors, and maps causal relation-
ships between target genes and their upstream transcriptional regulators [Margolin et al., 2006].
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As described previously, the b-cell regulatory network (BCRN) used in this study was an inte-
gration of two published datasets, and was generated from a combination of naı̈ve and germinal-
center human B-cells, human b-cell lymphomas and cell lines [Basso et al., 2005; Lefebvre et al.,
2010]. The BCRN has already been extensively validated in its ability to identify MYB and
FOXM1 as master regulators of proliferation in the germinal center (GC) [Lefebvre et al., 2010].
We felt the BCRN would be ideal for elucidating the transcriptional changes that occurred on the
human b-cell side of the heterokaryon during reprogramming, but were concerned that numer-
ous pluripotency markers were either not represented in the regulatory network, or did not have
significantly enriched activities according to VIPER.
We therefore also considered a mouse embryonic and epiblast stem-cell interactome, which
were generated from mouse embryonic stem cell (ES) and mouse epiblast stem cell (EpiSC) lines.
The ES interactome was generated by Dr. David Emlyn-Parfitt from the Shen Lab together with
Dr. Mariano Alvarez from the Califano Lab using two independent ES cell lines that were estab-
lished from the inner cell mass of blastocysts prior to implantation. The resulting ES stem cells
were perturbed using a combination of morphogens and drugs, sequenced using RNA-SEQ. The
resulting gene expression data was used generate regulatory networks using ARACNe, with the
computational work performed by Dr. Mariano Alvarez from the Califano Lab at Columbia.
The EpiSC interactome was generated by Dr. Hui Zhao from the Shen Lab with Dr. Mariano
Alvarez from the Califano Lab using two independent EpiSC cell lines. EpiSC cells are established
from the epiblast of post-implantation embryos, and gene expression profiles were generated using
Illumina microarrays. The gene expression profiles were also used to generate regulatory networks
using ARACNe, with the computational work also performed by Dr. Mariano Alvarez.
We also considered significant known differences between human and mouse ES cells. Al-
though both are isolated from the inner cell mass (ICM) of the pre-implantation embryo, there
are significant differences when it comes to required culture conditions and levels of pluripo-
tency markers. For instance, Mouse ES cells require leukemia inhibitory factor (LIF) and bone
morphogenetic protein (BMP) to grow [Thomson et al., 1998], whereas both human ES and
mouse EpiSC cells require fibroblast growth factor (FGF) and activin [Thomson et al., 1998;
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Tesar et al., 2007]. In addition, wnt/β-catenin signaling is not required for human ES cell self-
renewal[Davidson et al., 2012], but is known to maintain the self-renewal and pluripotency of
mouse ES cells [Anton et al., 2007; Hao et al., 2006] and is present in the mouse epiblast and
required for gastrulation [Ten Berge et al., 2011].
For the mouse ES and EpiSC regulatory networks, the mouse genes were converted to ho-
mologous human Entrez Gene IDs using a database from the Mouse Genome Informatics (MGI)
website http://www.informatics.jax.org/. This conversion resulted in the EpiSC reg-
ulatory network going from 1,014,160 predicted interactions between 1,393 mouse TFs and targets
to 443,181 predicted interactions between 1,041 human TFs and targets. For the ES regulatory
network, the conversion resulted in the ES regulatory network going from 809,637 predicted in-
teractions between 1,490 mouse TFs and targets to 416,298 predicted interactions between 1,105
human TFs and targets.
We attempted to assess which regulatory network was best suited for modeling the gene ex-
pression changes that occurred during reprogramming. Since the VIPER enrichment scores would
be driven by genes that had the highest differential expression between each sample and control,
we reasoned that the transcriptional network that best modeled the gene expression changes in our
context would have the highest overall enrichment scores for all TFs. To perform the comparison,
the enrichment scores for the top 100 TFs regulatory networks were compared for each of the
three regulatory networks. Only the top 200 predicted interactions were considered for each TF to
control for differences in regulatory network size.
Figure 2.20 shows the results of comparing the regulatory networks, comparing Bcell with 4-hr
(A), Bcell with 12-hr (B), Bcell with 48-hr (C) and Bcell with 120-hr timepoints, plotting the NES
values the top-100 TFs in each network. The results show that the B-cell regulatory network had
the highest overall enrichment scores for the heterokaryon signatures, and was therefore best suited
for describing the gene expression changes that occur after cell-cell fusion.
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2.5.2 Analysis of B-cell regulatory network, Murine ES and EpiSC regula-
tory networks on iPS dataset
In our heterokaryon samples, we observed that the mRNA expression levels of some of the pluripo-
tency markers such as POU5F1, NANOG and MYC were indeed upregulated after cell-cell fusion
(Figure 2.3, Figure 2.10C and Figure 2.10D) in a time-dependent manner. However, with the ex-
ception of KLF4, the VIPER activities of the pluripotency genes remained silenced until 5 days
after fusion. Moreover, although the mRNA expression levels of some of the pluripotency markers
POU5F1, NANOG and MYC were regulated, (Figure 2.3, Figure 2.10C and Figure 2.10D) many
are not represented in the BCRN, and their predicted activities cannot be measured with VIPER.
We had also observed that the BCRN had better over-all performance in modeling the gene
expression changes that occurred in the heterokaryons when compared to the mouse ES and EpiSC
regulatory networks (Figure 2.20). What was unclear was whether the poor performance of the ES
and EpiSC regulatory networks was due to their conversation from mouse to human genes, or if
the heterokaryons were going through a transition that was not well-modeled by the ES and EpiSC
regulatory networks.
To check whether the ES and EpiSC regulatory networks could indeed predict the activities for
known human pluirpotency markers, we applied their predictions to a publicly available human iPS
dataset (GSE41716) [Abyzov et al., 2012]. The iPS dataset was generated from 20 human iPSC
lines derived from primary skin fibroblast cells of 7 individuals, and treated with the four canonical
Yamanaka retroviral vectors to induce pluripotency. It consisted of 7 total fibroblast samples 22 iPS
samples. VIPER analysis was performed by comparing the expression of each iPS sample with the
average expression of the fibroblast samples as control. The BCRN, EpiSC and ES regulatory
networks were each used for VIPER analysis. Figure 2.21A shows the predicted activity of 4 well-
known pluripotency markers as predicted by the BCRN, EpiSC and ES regulatory networks. As
expected, we see significant increases in the predicted activity for most of the pluripotency markers,
especially in the results of the EpiSC regulatory network.
Figure 2.21B shows the predicted activity for the same 4 pluripotency markers in the het-
erokaryon samples using the BCRN, EpiSC and ES regulatory networks. Although the POU5F1,
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MYC and KLF4 showed positive VIPER-predicted activity in at least one timepoint (shown in red),
none of the timepoints had significant activities when tested for statistical significance (FDR <
0.01). Taken together, we were able to conclude that 1) when comparing the BCRN, ES and EpiSC
regulatory networks, the BCRN can best represent the gene expression changes that are occurring
in the heterokaryons during reprogramming. 2) The gene expression changes that are occurring in
the heterokaryons are through a different mechanism than those of iPS cells. As described more
fully in the main text, the heterokaryons seem to go through a transition that is better modeled by
the HSC-differentiation network, where known markers of hematopoiesis and hematopoietic stem
cell maintenance play a large role.
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Figure 2.1: Flow chart showing the generation of heterokaryon samples through cell-cell fusion
and subsequent FACS sorting of fused-cells and paired-end sequencing.
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Figure 2.2: Comparison of replicates for human gene expression during cell-fusion mediated re-
programming over five days. Spearman correlation is shown. Replicate 1 is shown on the x-axis
and Replicate 2 is shown on the y-axis.
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Figure 2.3: Expression of a representative set of human pluripotency markers in the heterokaryon
samples during reprogramming. The results show the raw-count of each gene normalized to
GAPDH
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Figure 2.4: Hierarchical clustering of heterokaryons samples show strong separation according to
time point. Plotting was performed using the complete agglomeration method using the expression
values of the top-2000 genes with the highest variance across all the samples.
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Figure 2.5: MAplot showing differential expression of human genes after cell-cell fusion with
murine ES cell. log2 fold-change of normalized counts are plotted on the y-axis and average log
expression values are shown on the x-axis. Blue-dashed line indicates fold-change of 1. Genes
displaying a significant (pval < 0.01) change in expression are shown in red.
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Figure 2.6: MAplot showing differential expression of mouse genes in an ES cell after cell-cell
fusion with a human b-cell. log2 fold-change of normalized counts are plotted on the y-axis and
average normalized counts are shown on the x-axis. Blue-dashed line indicates fold-change of 1.
Genes displaying a significant (pval < 0.01) change in expression are shown in red.
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Figure 2.7: Heatmap of VIPER activity for significant heterokaryon MR candidates. Heatmap
shows NES values of 633 TFs that were significant (FDR < 0.01) in the heterokaryon samples.
NES values were calculated using the VIPER algorithm, comparing the each heterokaryon sample
against the unfused B-cell. Positive NES values are shown in red, and negative NES values are
shown in blue.
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Figure 2.8: Plot showing total variance of VIPER activity in the heterokaryon dataset explained
by each eigengene after SVD analysis. Eigengenes are plotted on the y-axis, and the proportion of
variance is plotted on the x-axis.
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Figure 2.9: Plot showing the Eigengene levels across the sample timepoints for the top-2 Eigen-
genes of the heterokaryon dataset. The feature levels show a bimodal pattern across timepoints
after cell-cell fusion.
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Figure 2.10: VIPER-predicted activity and differential expression of a representative set of human
Bcell, pluripotency, and HSC markers during reprogramming. VIPER-predicted activities are rep-
resented by Normalized Enrichment Sores (NES), and were calculated using the VIPER algorithm,
comparing the heterokaryon samples of each time point (either 4h, 12h, 48h, 120h) against the un-
fused B-cell. Positive NES values are shown in red, and negative NES values are shown in blue.
Differential expression was calculated using EdgeR, which uses a negative-binomial distribution
to calculate the variance of reads. Log2FC values are shown, with positive values shown in orange,
and negative values shown in purple. A and B show the results for Bcell markers, C and D show
the results for pluripotency markers, and E and F show the results for HSC markers.
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Figure 2.11: Hierarchical model of hematopoietic development, adapted from Laurenti et al. and
Doulatov et al. [Laurenti et al., 2013; Doulatov et al., 2010]
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Figure 2.12: Hierarchical clustering of HSC samples shows significant variations between cells
of the same type. Plotting was performed using the complete agglomeration method, with the
expression values of the top-2000 genes with the highest variance across all the samples.
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Figure 2.13: Heatmap of predicted activity for significant HSC MR candidates. Heatmap shows
NES values of 445 TFs that were significant (FDR < 0.01) in each sample compared to unfused
B-cell samples. NES values were calculated using the VIPER algorithm, comparing the samples
of each cell-type against the unfused B-cell. Positive NES values are shown in red, and negative
NES values are shown in blue.
46
Figure 2.14: Results of transcriptional similarity between heterokaryons and celltypes in the HSC
dataset. Fisher’s Exact Test (FET) was used to calculate the significance of overlap between candi-
date TFs whose activities were both significant (FDR < 0.05) and positive in each celltype. –log10
of the p-values of the overlap are shown.
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Figure 2.15: Heatmap showing the clustering of the TFS that were part of the early and late tran-
scriptional programs in the Heterokaryons. Positive NES values are shown in red, and negative
NES values are shown in blue.
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Figure 2.16: Heatmap showing the clustering of the TFS that were part of the early and late tran-
scriptional programs in the HSC celltypes. Positive NES values are shown in red, and negative
NES values are shown in blue.
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Figure 2.17: Heatmap of predicted activity for significant Heterokaryon MR candidates that were
part of the “early” program. Positive NES values are shown in red, and negative NES values are
shown in blue. Differential expression was calculated using EdgeR and log2FC values are shown,
with positive values shown in orange, and negative values shown in purple.
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Figure 2.18: Heatmap of predicted activity for significant Heterokaryon MR candidates that were
part of the “late” program. Positive NES values are shown in red, and negative NES values are
shown in blue. Differential expression was calculated using EdgeR and log2FC values are shown,
with positive values shown in orange, and negative values shown in purple
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Figure 2.19: Model of heterokaryon reprogramming, shown alongside hierarchical model of
hematopoietic development, adapted from Laurenti et al. and Doulatov et al.[Laurenti et al., 2013;
Doulatov et al., 2010]
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Figure 2.20: NES values for the top-100 TFs comparing Bcell with 4-hr (A), Bcell with 12-hr (B),
Bcell with 48-hr (C), and Bcell with 120-hr timepoints.
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Figure 2.21: Figure shows the results of comparing the regulatory networks (interactomes) com-
paring Bcell with 4-hr (A), Bcell with 12-hr (B), Bcell with 48-hr (C), and Bcell with 120-hr
timepoints.
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TotalReads Human.Unique Mouse.Unique Multi-mapping
Bcell 28,273,008 27,680,415 1,765 590,828
Bcell 23,071,287 22,450,851 1,402 619,034
Bcell 25,572,699 25,020,566 1,461 550,672
Het4h 26,385,518 8,357,365 17,498,299 529,854
Het4h 33,172,158 9,984,775 22,655,854 531,529
Het4h 83,758,127 41,070,282 41,062,055 1,625,790
Het12h 71,139,709 32,242,448 37,825,136 1,072,125
Het12h 75,805,230 37,458,398 36,854,827 1,492,005
Het12h 78,824,375 39,022,278 38,117,926 1,684,171
Het48h 51,280,183 3,271,949 47,294,808 713,426
Het48h 51,742,113 3,034,489 47,850,548 857,076
Het48h 48,586,528 8,151,493 39,044,433 1,390,602
Het120h 63,139,366 1,115,469 60,562,409 1,461,488
Het120h 53,906,586 798,759 51,915,397 1,192,430
Het120h 67,176,421 754,427 65,038,187 1,383,807
Table 2.1: Table shows the number of reads that mapped to either the human (hg19) or mouse
(mm10) genomes according to the TopHat method. For each sample, the table shows the total
number of reads that mapped, the number of reads that mapped uniquely to the human and mouse







Bcell 28,273,008 28,271,243 1,765
Bcell 23,071,287 23,069,885 1,402
Bcell 25,572,699 25,571,238 1,461
Het4h 26,385,518 8,670,944 17,714,574
Het4h 33,172,158 10,296,287 22,875,871
Het4h 83,758,127 41,925,026 41,833,101
Het12h 71,139,709 32,842,567 38,297,142
Het12h 75,805,230 38,254,324 37,550,906
Het12h 78,824,375 39,931,191 38,893,184
Het48h 51,280,183 3,674,748 47,605,435
Het48h 51,742,113 3,495,871 48,246,242
Het48h 48,586,528 8,858,769 39,727,759
Het120h 63,139,366 1,897,669 61,241,697
Het120h 53,906,586 1,506,793 52,399,793
Het120h 67,176,421 1,488,917 65,687,504
Table 2.2: Table shows the number of reads that mapped to either the human (hg19) or mouse
(mm10) genomes after multi-mapping reads were assigned to either the mouse or human genome
using the “fair-split” method. For each sample, the table shows the total number of reads that
mapped, the final number of reads that mapped to the human and mouse genome after correction.
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GreaterThan0 GreaterThan1 GreaterThan5
Bcell 17,029 16,082 14,418
Bcell 17,025 15,975 14,338
Bcell 17,057 16,048 14,443
Het4h 15,071 14,054 12,474
Het4h 15,281 14,362 12,827
Het4h 17,188 16,435 15,020
Het12h 17,214 16,561 15,084
Het12h 16,215 15,473 14,064
Het12h 16,456 15,653 14,239
Het48h 14,138 13,054 11,518
Het48h 14,192 13,072 11,451
Het48h 15,884 14,814 12,977
Het120h 13,410 12,028 9,817
Het120h 11,921 10,741 8,317
Het120h 11,211 9,536 6,359
Table 2.3: Table shows the number of genes that had greater than 1 read assigned to it (out of
22,932 total annotated genes in the human genome.
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GreaterThan0 GreaterThan1 GreaterThan5
Bcell 134 71 34
Bcell 139 70 35
Bcell 126 68 30
Het4h 17,730 16,998 15,608
Het4h 17,882 17,236 15,895
Het4h 17,612 16,937 15,625
Het12h 17,708 17,154 15,887
Het12h 17,282 16,667 15,404
Het12h 17,388 16,776 15,448
Het48h 17,600 16,866 15,618
Het48h 17,763 17,132 15,993
Het48h 18,167 17,442 16,196
Het120h 18,247 17,605 16,492
Het120h 18,184 17,711 16,494
Het120h 18,296 17,682 16,567
Table 2.4: Table shows the number of genes that had greater than 1 read assigned to it (out of
23,079 total annotated genes in the mouse genome
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Number of Significant MR candidates (FDR < 0.01)
4-hours after cell-cell fusion 169
12-hours after cell-cell fusion 200
48-hours after cell-cell fusion 106
120-hours after cell-cell fusion 64
Table 2.5: Number of Master Regulators (MRs) that were predicted in each timepoint (FDR <
0.01).
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Table 2.6: NES values for Heterokaryon TFs that were significantly associated with Eigengene1
Name Het4h Het12 Het48h Het120h
AATF 4.543 1.518 -2.372 -1.320
ARHGAP35 2.172 2.575 1.013 1.570
ASH2L 1.805 3.364 2.638 2.154
ATAD2 4.171 6.900 2.323 2.134
BUD31 4.872 5.853 1.518 -1.323
CARHSP1 3.324 4.407 6.150 2.710
CBX2 4.972 4.176 1.070 0.305
CCRN4L 3.885 3.627 -1.524 -2.300
CHAMP1 2.708 3.371 0.966 0.815
CREB3 2.299 2.437 2.537 0.031
CREM 1.123 3.672 -1.452 -2.367
DMAP1 2.799 2.849 1.741 -0.550
E2F1 5.530 4.551 1.604 -0.545
E2F2 6.573 6.011 2.385 1.818
E2F6 2.763 3.417 -5.651 -4.576
E2F7 7.408 8.296 5.779 2.270
E2F8 8.996 10.467 6.720 4.615
ECSIT 5.210 3.108 1.368 -1.422
ENO1 4.656 2.521 0.072 0.354
FOXM1 10.100 8.889 5.362 2.396
FUBP1 4.084 4.318 1.374 3.333
GABPB1 2.542 4.371 -2.339 -2.235
GTF2H4 4.341 3.410 2.516 0.312
GTF2IRD1 3.562 3.600 0.011 1.606
GZF1 1.104 4.556 -0.266 -0.158
HDAC1 1.816 1.956 4.663 3.900
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HDGF 5.749 5.919 0.481 0.368
HLTF 3.882 6.754 4.518 3.706
HMGA1 5.444 2.161 2.314 0.207
HMGB1 2.907 5.386 3.323 3.378
HMGB2 6.350 8.586 5.777 4.188
HMGN5 2.850 4.127 1.600 -0.007
HNRNPAB 8.661 8.957 2.849 2.259
HSF2 1.512 3.356 -1.888 -0.530
IKZF5 2.913 3.714 -2.045 0.500
ILF2 5.922 5.817 -0.782 -0.813
ILF3 5.285 2.222 -1.339 0.691
KDM1A 5.808 3.711 2.958 2.299
MAZ 6.143 1.368 0.058 -0.150
MNX1 2.082 2.890 1.703 1.037
MRPL28 8.491 7.121 3.800 0.993
MRRF 3.248 3.290 -4.592 -4.436
MTA2 4.257 3.924 -0.785 -0.291
MXD3 2.041 2.545 3.225 2.004
MYBL2 8.945 8.727 6.145 3.542
NAT14 4.136 2.389 2.491 -0.073
NFYA 2.557 1.687 0.165 1.012
NR2F6 6.098 5.415 0.910 2.198
PA2G4 5.216 3.137 -4.946 -5.014
PHF5A 3.685 4.654 0.761 -0.201
PITX1 6.277 4.879 -0.461 -0.559
PLAGL2 4.208 2.498 -2.272 -2.731
PREB 3.970 4.164 1.290 -0.158
PRKDC 6.401 6.080 1.973 4.338
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PSMC3IP 5.789 7.087 0.451 0.063
PTTG1 8.772 10.245 8.582 4.624
PURB 3.587 5.602 -0.988 -2.163
RFXANK 6.241 7.156 3.805 0.354
RFXAP 2.581 3.701 1.413 1.770
SARNP 5.199 7.567 5.038 1.473
SCMH1 6.303 3.742 3.047 3.084
SMARCA4 4.092 1.527 1.458 1.221
TADA2A 2.930 2.637 -1.924 -1.838
TAF12 1.608 4.715 3.383 1.100
TAF1B 3.813 5.687 -0.455 -0.813
TAF5 4.787 6.774 0.146 -0.914
TAF9 4.098 7.709 0.480 -0.473
TAF9B 1.886 3.234 0.295 0.821
TCF19 5.102 5.239 4.705 2.881
TCF3 3.128 1.439 2.462 1.211
TFAM 4.050 6.567 -1.645 -0.656
TFAP4 3.056 3.616 -0.240 0.241
TFDP1 6.924 8.627 6.414 4.172
TFDP2 2.218 3.585 -0.497 -0.559
THAP7 3.727 1.292 -0.877 -1.835
TOP2A 8.939 10.126 6.888 4.756
UHRF1 9.938 9.326 6.130 4.017
WHSC1 8.589 7.152 4.670 2.999
YBX1 6.092 6.491 2.652 2.485
YEATS4 6.043 8.922 3.776 1.309
ZBED4 4.087 2.913 -2.311 -0.847
ZC3HC1 3.289 2.379 -2.882 -2.686
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ZCCHC4 4.086 3.843 0.173 0.062
ZCRB1 0.782 4.113 1.620 -0.301
ZDBF2 1.580 2.932 1.923 1.015
ZDHHC16 4.238 4.345 -0.287 -1.737
ZFPL1 3.992 2.256 0.266 -1.976
ZMAT5 3.073 2.474 2.787 -0.095
ZMYND19 6.231 3.468 -3.816 -3.495
ZNF174 4.455 4.718 -2.413 -3.180
ZNF207 6.071 6.775 0.949 2.146
ZNF250 2.321 2.238 1.425 0.497
ZNF259 3.954 3.774 -5.315 -5.148
ZNF282 4.617 1.833 0.481 -1.582
ZNF326 2.248 3.761 -3.014 -1.342
ZNF367 4.541 6.792 2.838 1.980
ZNF511 2.662 2.844 -1.308 -2.913
ZNF552 3.091 2.930 -1.417 -1.576
ZNF576 3.832 3.012 -2.835 -2.514
ZNF593 5.758 5.692 -2.610 -3.423
ZNF653 4.467 2.150 0.926 0.096
ZNF670 3.003 3.627 -3.435 -1.389
ZNF747 2.505 3.142 -0.561 -1.823
ZNHIT1 3.722 4.847 4.393 1.094
ZNHIT3 1.735 3.778 3.575 0.996
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Table 2.7: NES values for Heterokaryon TFs that were significantly associated with Eigengene6
Name Het4h Het12 Het48h Het120h
AKNA -2.825 -6.503 3.724 2.997
ALS2CR8 -2.326 0.183 2.050 2.418
ASH1L -4.155 -3.424 1.498 3.693
BAZ2B -2.148 -2.705 4.588 5.026
BCL11A -2.983 -2.277 2.987 2.243
CBFA2T2 -1.138 -3.141 2.202 2.715
CBFA2T3 0.220 -1.581 2.593 2.103
CGGBP1 -2.611 0.289 1.996 2.655
CNOT8 -3.093 -0.733 4.056 4.675
CREB1 -4.687 -2.142 1.573 2.923
CREBZF -2.112 -1.460 1.054 3.279
DMTF1 -2.816 -2.914 3.015 3.585
ELF1 -2.012 -0.312 1.495 3.683
FLI1 -2.634 -0.762 3.686 3.128
FOXN3 -2.498 -2.778 3.013 2.615
FOXO1 -0.955 -0.864 2.850 2.852
GATA1 -3.216 -3.715 2.861 1.394
GTF2I 0.778 0.112 1.755 3.522
HBP1 -5.360 -3.934 2.962 2.065
HCLS1 -1.455 -2.715 5.913 3.405
HDAC1 1.816 1.956 4.663 3.900
IFI16 -3.810 -3.397 1.842 1.461
IRF2 -1.918 -2.976 4.728 2.944
IRF8 -3.875 -3.686 4.545 2.318
IRF9 -5.574 -7.158 2.826 1.340
KLF12 -2.864 -1.214 4.590 3.620
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LYL1 -0.725 -1.550 5.069 2.773
MEF2C -2.820 -0.276 3.604 3.567
MSL3 -3.131 -1.231 2.765 2.200
MYBL1 0.010 1.085 4.805 3.233
NR2C2 -4.493 -3.318 0.579 2.528
POU2F2 -1.903 -4.024 2.881 1.368
RBL2 -6.015 -5.206 2.421 2.534
RERE -0.358 -3.939 2.291 3.288
RFX5 -2.632 -2.376 3.778 2.704
SP140 -3.840 -3.315 3.101 0.956
SPI1 1.393 -1.663 3.842 1.262
SPIB 0.005 -0.088 4.447 2.099
STAT2 -1.082 -2.467 4.916 3.165
STAT5B -1.264 -0.988 2.801 2.955
STAT6 -1.631 -5.465 2.694 1.077
TADA3 1.164 0.214 4.372 2.056
TAF10 -1.452 -2.289 5.065 2.162
TCEAL1 -2.477 -0.754 2.264 1.686
TFEB -1.576 -2.273 2.782 1.377
ZBTB20 -4.185 -3.492 3.746 3.861
ZC3H6 -2.718 -1.188 1.829 2.028
ZCCHC11 -3.312 -3.614 2.095 2.060
ZCCHC6 -2.229 -0.822 2.599 2.390
ZDHHC17 -3.765 -3.623 0.806 3.139
ZFC3H1 -3.625 -3.812 0.490 3.763
ZFP161 -2.205 0.608 3.708 3.302
ZFP90 -4.046 -4.074 2.092 1.380
ZFYVE21 -0.369 -0.867 2.805 1.681
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ZHX2 -1.316 -1.112 4.998 3.970
ZMAT1 -4.296 -3.626 2.493 3.840
ZMYM2 -3.633 -1.092 1.146 3.018
ZNF292 -3.893 -2.265 1.987 2.974
ZNF395 0.752 -0.306 3.015 2.023
ZNF512 -0.888 -2.147 1.529 3.258
ZNF581 1.701 0.588 3.640 1.530
ZNF611 -2.437 -2.978 1.940 2.693
ZNF652 -2.529 -0.104 1.973 2.730
ZNF763 -2.319 -2.089 2.378 1.490
ZSWIM6 -2.708 -2.172 1.556 2.817
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Chapter 3
Identifying Candidate Drivers of alcohol
dependence-induced excessive drinking by
assembly and interrogation of brain-specific
regulatory networks
3.1 Introduction
Development of alcoholism involves a complex interplay of distinct molecular mechanisms. Thus,
elucidating the key molecular determinants of the transition to dependence will require innovative
genome-wide modeling strategies [Guo et al., 2008] In this study, we tested whether a systems
biology approach that has been highly effective in elucidating drivers of cancer [Carro et al., 2010;
Aytes et al., 2014; Chudnovsky et al., 2014; Piovan et al., 2013; Sumazin et al., 2011; Della Gatta
et al., 2012] and developmental phenotypes [Zhao et al., 2009; Lefebvre et al., 2010] could be
effective in elucidating the mechanisms that control the neuroadaptive changes associated with
excessive drinking. This approach can potentially lead to novel insights into the disease process
and ultimately more effective therapeutic targets.
In order to produce the first genome-wide, transcriptional model, or interactome, of a mam-
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malian Central Nervous System (CNS), we used the Algorithm for the Reconstruction of Accurate
Cellular Networks (ARACNe) [Basso et al., 2005; Margolin et al., 2006], which is based on an
information-theoretic approach for the inference of the targets of transcription factors (TF), i.e., the
TF-regulon. Specifically, we analyzed a collection of 96 gene expression profiles (GSE60966) from
microdissected brain regions of the central reward and stress pathways in a rat behavioral model
of dependent and nondependent alcohol self-administering rats [O’Dell et al., 2004; Roberts et al.,
2000]. In this model, rats are chronically exposed to intermittent alcohol vapor to intoxication
to induce dependence. Dependent rats in this model rapidly escalate their alcohol intake during
repeated withdrawal periods and show compulsive responding for alcohol [O’Dell et al., 2004;
Roberts et al., 2000; Vendruscolo et al., 2012]. In particular, dependent rats self-administer suf-
ficient amounts of alcohol to reach blood alcohol levels comparable to excessive drinking in al-
cohol use disorders humans [Richardson et al., 2008; Gilpin et al., 2009], and manifest physical
and motivational (anxiety, dysphoria, and hypohedonia) signs of withdrawal during acute and pro-
tracted abstinence periods [O’Dell et al., 2004; Roberts et al., 2000; Vendruscolo et al., 2012;
Francesconi et al., 2009; Vendruscolo and Roberts, 2013]. Compulsive alcohol seeking in depen-
dent rats is reflected by increased progressive-ratio responding and persistent alcohol consumption
despite punishment [Vendruscolo et al., 2012]. Dependent rats also exhibit electrophysiological
changes in the extended amygdala during withdrawal [Francesconi et al., 2009; Roberto et al.,
2010].
We interrogated the CNS transcriptional-interactome with the Master Regulator Inference Al-
gorithm (MARINa) [Carro et al., 2010; Lefebvre et al., 2010] to identify the key genes that drive
the expression of the specific gene signatures associated with alcohol dependence (master regula-
tor genes, MRs). Rather than selecting candidate genes based on existing knowledge, e.g., scien-
tific literature, or on differential expression, MARINa computes the enrichment in differentially
expressed genes of the ARACNe-inferred targets of a TF (regulon). This is used to assess the
TF’s role in implementing the gene expression signature representative of the phenotypes of inter-
est (e.g., alcohol nondependent vs. alcohol dependent, in the present setting) [Carro et al., 2010;
Lefebvre et al., 2010]. This is motivated by the fact that many TFs are post-translationally regu-
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lated and, thus, their transcriptional activity may not be directly proportional to their expression
levels. This methodology has been highly successful in elucidating key biological drivers of can-
cer and developmental phenotypes [Carro et al., 2010; Della Gatta et al., 2012; Zhao et al., 2009;
Lefebvre et al., 2010; Compagno et al., 2009; Mani et al., 2008], where MARINa-inferred MRs
have been validated as causally related to phenotype presentation with high probability (¿70%).
However, this approach had not been previously tested in the context of complex CNS diseases.
Here, we report on several transcription factors predicted by MARINa as key drivers of brain-
region-specific gene expression signatures associated with a history of alcohol dependence in rats.
Of these, Nr3c1, the gene coding for the glucocorticoid receptor (GR), was one of the highest-
ranking MRs in several brain regions from which signatures were derived, including the central
nucleus of the amygdala (CeA), medial prefrontal cortex (mPFC), and core sub-region of the nu-
cleus accumbens (NAc), where it was recruited both in the context of nondependent and dependent
alcohol drinking; and the shell of the NAc and the ventral tegmental area (VTA), where Nr3c1/GR
was recruited selectively by a history of alcohol dependence. As found in the associated manuscript
in Genome Biology, under the title “Identifying candidate drivers of alcohol dependence-induced
excessive drinking by assembly and interrogation of brain-specific regulatory networks”.,The re-
sults suggest that glucocorticoid-dependent neuroadaptive changes in these brain regions may con-
tribute to excessive drinking during protracted abstinence. The experimental results described in
the manuscript show that systemic GR antagonism with mifepristone (RU38486) blocks compul-
sive alcohol drinking during protracted abstinence [Vendruscolo et al., 2012]. In the present study,
we tested the functional role of the GR in specific brain regions such as the NAc and VTA, where
Nr3c1/GR was unexpectedly predicted to be a high-ranking master regulator, via intracerebral (IC)
administration of mifepristone. Here we found that GR antagonism with mifepristone in either the
NAc or the VTA selectively decreased escalated alcohol intake in rats with a history of alcohol
dependence.
These results identify a key role of regulatory networks downstream of GR in the neuroadaptive
changes that take place in the progression from alcohol naive to alcohol drinking and from nonde-
pendent alcohol drinking to alcohol dependence, and support the potential of the present systems
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biology approach to deconvolve dysregulated gene regulatory networks in diseases affecting the
CNS and to identify therapeutic targets for excessive alcohol drinking. The results of the analysis
can be found at the full online of the paper[Repunte-Canonigo et al., 2015], and the experimental
results were performed by Dr. Vez Repunte-Canonigo, who was cited as a co-first author in the
manuscript.
3.2 Results
3.2.1 Regulatory network assembly
We reconstructed a transcriptional-interactome from a dataset of 96 gene expression profiles (GEP)
from 8 brain regions believed to be relevant in alcohol’s reinforcing properties using the Affymetrix
RN230.2 platform. Specifically, the following brain regions were microdissected and analyzed
from nondependent and dependent alcohol self-administering rats as well as age-matched alcohol
naive rats: (a) mPFC, (b) shell and (c) core NAc sub-regions, (d) CeA), (e) BLA, (f) dorsolateral
and (g) ventral bed nucleus of the stria terminalis (BNST), and (h) VTA (Fig.3.1). To improve the
accuracy and reproducibility of the analyses, the Cleaner algorithm [Alvarez et al., 2009] was used
to normalize the GEP data. Cleaner maps individual Affymetrix probes to the most recent Refseq
transcript database, thus eliminating probes mapping to multiple genes or to incorrect and/or in-
tragenic regions [Alvarez et al., 2009]. Cleaner also clusters probes into probesets, based on probe
correlation across the entire GEP dataset, producing probesets that optimally monitor the expres-
sion of individual alternative gene transcripts, thus excluding low-quality and incorrectly matched
probes [Alvarez et al., 2009]. Cleaner identified 7,019 high-quality probesets in the Affymetrix
RNU230.2 GEP data, representing the transcripts of 6,818 expressed genes, down from the 19,456
probesets originally represented on the microarray platform. Thus, only about a third of the moni-
tored probes were considered to be high quality and mapped to expressed genes.
The Cleaner-normalized dataset was then processed by ARACNe to produce a genome-wide
transcriptional-interactome. ARACNe first computes the Mutual Information (MI), I[TF ; t], be-
tween each transcription factor, TF, and candidate target, t, in the dataset [Basso et al., 2005].
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TF-target pairs are considered as candidate interactions if their MI is statistically significant (p ≤
0.05, Bonferroni corrected for multiple hypothesis testing). However, indirect interactions (i.e., via
any other TF) are removed, based on the Data Processing Inequality property of information theory
[Margolin et al., 2006]. The ARACNe-inferred transcriptional network included 78,090 predicted
TF-target interactions between 664 TFs and 6,716 targets, with an average of about 100 targets per
TF (see methods for details on the ARACNe parameters used for this analysis).
3.2.2 Regulatory network interrogation and validation
The CNS transcriptional-interactome was then interrogated using the MARINa algorithm [Carro
et al., 2010; Lefebvre et al., 2010] to identify candidate MRs driving the gene expression signatures
associated with nondependent and dependent alcohol self-administration. This includes all genes,
ranked according to their differential expression in rats with a history of dependent vs. nondepen-
dent self-administration, as well as in both groups compared with alcohol naive rats. MARINa
analyzes each TF in the transcriptional-interactome by measuring the enrichment of its ARACNe-
inferred targets in the gene expression signature. The statistical significance of the enrichment is
computed by Gene Set Enrichment Analysis (GSEA) [Subramanian et al., 2005]. Figure 3.4 shows
the results of MARINa for the core sub-region of the nucleus accumbens (NAc) sorted by the TFs
or MR candidates’ differential activity (NES) in alcohol dependence. Each row of the plot shows
the result of MARINa for statistically-significant TFs or MR candidates. The number of MRs pre-
dicted in each region, as well as the top-25 MR candidates for each region and comparison are
shown in Table3.1 and Figure3.2 and 3.3. The overlap among MRs inferred from different brain
regions and the associated p-value based on Fisher’s Exact test (FET) can be found in Table 3.1.
Of particular interest, the core and shell sub-regions of the NAc, as well as the VTA, showed
a highly significant fraction of overlapping MRs (p < 0.01), suggesting that some common neu-
roadaptations may affect elements of the reward-motivational systems Table 3.2a. The VTA also
showed significant MR overlap with elements of the extended amygdala: the CeA (p < 0.01), and
dorsolateral BNST (p < 0.01) in the nondependent vs. dependent gene signature Table 3.2b. While
regions with the most significant MR overlap were generally closer in the GEP hierarchical clus-
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tering analysis (Figure 3.6, Table 3.2a), this was not always the case. For instance, the dorsolateral
BNST and ventral BNST shared only 1 common MR despite similar gene expression programs
(Figure 3.7, Table 3.2b). We found no candidate MRs that were enriched in every region, suggest-
ing that the effect of alcohol may be largely mediated by region-specific neuroadaptations (Figure
3.5, Table 3.2b). We also found that for the nondependent vs. dependent gene signatures, the most
significant MR candidates were in the NAc core, shell, VTA, CeA, BLA, and dorsal BNST regions,
whereas the most significant MR candidates in the alcohol naive vs. nondependent signature were
in the mPFC, NAc core, NAc shell, dorsal and ventral BNST, and VTA regions (Table3.1). These
results suggest a differential and progressive recruitment of brain regions of the reward and stress
system in the transition to dependence.
Among the MRs inferred in the analysis, Nr3c1, the gene coding for the GR, was one of
the highest ranking on the basis of differential activity (e.g., Figure 3.4). We thus assessed the
functional relevance of the network predictions through behavioral validation of this gene in the
specific brain regions identified by the analysis. As shown in Figure 3.5, we first validated the
accuracy of the ARACNe-inferred Nr3c1/GR regulon (i.e., the set of its inferred transcriptional
targets; the complete ARACNe-inferred Nr3C1/GR regulon is shown in Figure 3.8). ARACNe-
inferred targets of the Nr3c1 TF (i.e., the Nr3c1 regulon) were found to be significantly enriched
in genes differentially expressed following shRNA-mediated silencing of this TF (p < 0.005
by GSEA analysis [Subramanian et al., 2005], Figure 3.5A,B). Promoters of ARACNe-inferred
Nr3c1/GR targets were found to be significantly enriched in canonical Nr3c1/GR binding sites
Figure 3.5C; p < 0.05), compared to randomly selected promoters from non-ARACNe predicted
targets. Binding site enrichment analysis was performed using the position-specific-scoring-matrix
for Nr3c1/GR (MA0013.1) downloaded from the JASPAR database [Mathelier et al., 2013]. The
position-specific-scoring-matrix was scored using the maximum-likelihood method outlined by
Conlon et al. [Conlon et al., 2003]. Taken together, these independent analyses suggest that the
ARACNe-inferred regulon is highly enriched in bona-fide, physical Nr3c1/GR targets. Note that
since ARACNe does not use any sequence related knowledge, such as the presence of binding sites
in the promoters of predicted targets, the evidence from the two analyses is statistically independent
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and can thus be combined.
MARINa analyses of alcohol naive vs. nondependent and dependent alcohol self-administering
rats revealed that Nr3c1/GR is recruited in a brain-specific manner during the progression from
alcohol naive to nondependent and, in turn, to dependence. Nr3c1/GR is activated in the CeA and
mPFC in nondependent alcohol self-administering rats, as compared to alcohol naive rats, and it
is further increased increases only slightly in these regions after the transition to dependence. In
contrast, Nr3c1/GR activity increases progressively during alcohol exposure and dependence in the
VTA and NAc core, while in the NAc shell, Nr3c1/GR activation is seen only after the transition
to dependence (Figure 3.9, Table 3.3a,3.3b).
The cited manuscript will describe the functional role of GR on alcohol self-administration
through GR pharmacological antagonism in specific brain regions in which Nr3c1/GR was found to
be a high-ranking master regulator, including the NAc and VTA. The manuscript will also contain
the results of the experimental validation of a second MR of alcohol dependence Psip1, which was
found to be differentially activated by alcohol dependence in the CeA in alcohol dependence and
was not, to our knowledge, previously implicated in the motivation for alcohol.
Computationally, we computed intra-network functional similarity to generate new hypothe-
ses on candidate GR transcription co-factors (Tfco) and signaling molecules associated with pro-
tracted abstinence in dependent rats by using the CNS transcriptional-interactome and the CNS
Signaling Molecule interactome, which was constructed using the same parameters as the CNS
transcriptional-interactome and a list of known signaling molecules regulating the GR instead of
TFs [Piovan et al., 2013; Margolin et al., 2006]. Correlation was calculated between each TF or
signaling molecule with more than 25 ARACNe-inferred targets. Target correlation was calcu-
lated using Pearson correlation, and statistical significance was calculated by estimating the cor-
relations between random regulons of the same size. Eight signaling molecules (Cdk5, Ywhah,
Mapk3, Cdh2, Hsp90aa1, Med14, Txn1, Med1) had significant correlation with Nr3c1/GR activ-
ity, as shown by the heatmap in Figure 3.10. Additionally, Nr3c1/GR activity was significantly




Alcoholism is a chronically relapsing disorder characterized by a compulsion to seek and take
alcohol, loss of control in limiting intake, and emergence of a negative emotional state when
access to alcohol is prevented. It has been proposed that in alcoholism, the brain reward and
stress circuitry fails to maintain homeostatic regulation in the face of chronic excessive drink-
ing and withdrawal but instead develops a set of neuroadaptations to cope with high levels of
alcohol exposure [Koob and Le Moal, 2001; Koob, 2011; Koob and Volkow, 2010b]. Using this
conceptual framework, it has been hypothesized that alcoholics continue to drink or relapse to
drinking in an attempt to reverse the emotional consequences of the functional dysregulations of
their reward and stress systems [Vendruscolo et al., 2012; Koob and Le Moal, 2001; Koob, 2011;
Koob and Volkow, 2010b]. Because of the complexity of alcohol’s effects, a systems biology ap-
proach should be particularly well suited to investigate the gene dysregulations associated with
alcohol dependence [Guo and Zakhari, 2008]. Here, we used a strategy combining both compu-
tational and experimental approaches to identify genes that control the transcriptional regulatory
networks that are dysregulated in rats with a history of alcohol dependence.
The present systems biology approach is aimed at identifying key genes that are causally related
to the phenotype of interest, rather than on the identification of those that are merely statistically
associated with it (i.e., gene activity vs. gene expression). This is predicated on the reconstruction
(reverse-engineering) of accurate transcriptional regulatory networks (interactome) for a biologi-
cally relevant system, where networks are generated in an unbiased fashion from high-throughput
experimental data. This strategy does not lead to the compilation of long lists of differentially
expressed genes, but it identifies a much smaller number of key regulators that directly control
the differentially expressed genes and are thus much more likely to be causal. Such an approach
thus provides high-probability hypotheses for the elucidation of mechanistic and context-specific
regulatory events determining the phenotype. Importantly, regulators are not prioritized by their
differential expression, which is a poor predictor of regulatory activity, but rather by the differ-
ential expression of their targets in a phenotype of interest (e.g., history of alcohol dependence).
The advantage of using the TF’s differential activity instead of its differential expression is ex-
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emplified by Nr3c1/GR, which only showed slight increases in expression in regions where it
exhibited the highest levels of activity. In fact, Nr3c1/GR is regulated through multiple transcrip-
tional, post-transcriptional, and post-translational mechanisms [Barnes, 2011]. Thus, as expected,
the Nr3c1/GR differential activity - as determined by the differential expression of its set of target
genes of the regulon - was considerably greater than Nr3c1/GR differential expression. For exam-
ple, Nr3c1/GR was the most differentially active regulator by MARINa analysis in the NAc core
region of the NAc (Figure 3.4) but only the 544th most differentially expressed gene in the same
region (t-statistic: 2.08 and p = 0.08). A limitation of the present systems biology strategy is that
TFs with few targets are not efficiently identified by MARINa as MRs. However, as true MRs drive
the phenotype, they typically have numerous targets. An additional limitation is that a small num-
ber of regulators whose regulon significantly overlaps with that of a true MR may result in false
positives, although this is mitigated by our pleiotropy analysis. Lastly, ARACNe may invert the
predicted direction of regulation when feedback loops are present (the protein negatively regulates
its own expression).
We focused our attention on the Nr3c1/GR gene regulatory network because it was found
to be one of the highest-ranking master regulators showing differential activation in multiple
brain regions of rats with a history of dependence. Additionally, evidence suggests that sustained
activation of the hypothalamic–pituitary–adrenal (HPA) axis by alcohol intoxication and with-
drawal and consequent overactivation of GRs induce neuroadaptive changes that drive compul-
sive alcohol drinking in alcohol dependence [Vendruscolo et al., 2012]. In the present study, tran-
scriptional network analysis predicted Nr3c1/GR to be a high-ranking master regulator differen-
tially regulated in multiple brain regions of animals with a history of alcohol exposure includ-
ing the mPFC, CeA, NAc core and shell, as well as the VTA. We behaviorally validated inhi-
bition of Nr3c1/GR in both the NAc and VTA with the GR antagonist mifepristone (RU38486),
which selectively decreased escalated alcohol self-administration during protracted abstinence in
rats with a history of dependence. Consistent with these findings, evidence suggests that these
brain regions are sensitive to the effects of stress and glucocorticoids. In fact, corticosterone,
the main glucocorticoid hormone in rodents (equivalent to cortisol in humans), modulates VTA
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dopamine cell activity and NAc dopaminergic responses [Tye et al., 2009; Piazza et al., 1996;
Cho and Little, 1999]. Glucocorticoids have also been shown to act on the NAc to stimulate al-
cohol consumption in rats [Fahlke and Hansen, 1999]. Thus, in light of the role of glucocorti-
coids in the development of compulsive alcohol drinking in alcohol dependence [Vendruscolo and
Roberts, 2013], the present results suggest that glucocorticoid-induced neuroadaptations in the
VTA and NAc are key to the neuroadaptations that dysregulate the reward system and contribute
to driving excessive alcohol drinking associated with a history of alcohol dependence. While the
mesocorticolimbic system, which has origin in the VTA, has an established role in mediating mo-
tivation driven by positive reinforcement, VTA circuits are also increasingly implicated in the
neurobiological mechanisms behind negative affect, aversion and dependence [Root et al., 2014;
Grieder et al., 2014; Diana et al., 1993; Nader and van der Kooy, 1997]. The present results point
to a role for glucocorticoid-mediated neuroadaptive changes in the VTA and NAc in motivation
for alcohol in dependent animals. Additionally, because the VTA and NAc are extensively inter-
connected with regions of the extended amygdala such as the CeA [McFarland et al., 2004], BLA
[Stuber et al., 2011] and BNST [Dumont et al., 2008; Briand et al., 2010], the glucocorticoid-
induced neuroadaptations within these regions are predicted to broadly affect the reward-stress-
motivational circuits during excessive drinking associated with ongoing dependence.
Lastly, a measure of intra-network functional similarity was used to generate new hypotheses
on transcription co-factors (Tfco) and signaling molecules associated with protracted abstinence
in dependent rats. Among signaling molecules showing the greatest degree of co-regulation with
GR across the experimental perturbations of the study were Mapk3 (ERK1) [Sanna et al., 2002],
previously shown to be regulated by alcohol [Sanna et al., 2002; Hansson et al., 2008], and Med14
(Mediator of RNA polymerase II transcription subunit 14), an ERK-regulated transcriptional reg-
ulator [Galbraith et al., 2013]; as well as several key regulators of GR such as Nfkb1, Smarca4,
Ncor2. These results suggest candidate molecular targets that may be manipulated to affect GR
activity, as previously shown in the cancer setting for MRs driving specific pathologic phenotypes
[Carro et al., 2010; Sumazin et al., 2011; Wang et al., 2009].
The overarching hypothesis behind the present study was that understanding the dysregulations
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of the gene regulatory network that underlie the neuroadaptive changes associated with excessive
alcohol drinking will allow the identification of new and more effective therapeutic targets for alco-
hol dependence. Here, we showed that gene network analysis of the transcriptional dysregulations
associated with protracted abstinence in rats with a history of alcohol dependence reveal a large set
of transcription factor dysregulations. The gene network predictions were validated for Nr3c1/GR
and Psip1, a new alcohol-regulated gene. Nr3c1/GR is a gene of key significance to the paradigm
of alcohol dependence-induced excessive drinking; however, the results highlighted a previously
unrecognized key role of dysregulation of the Nr3c1/GR regulon in the NAc and VTA in excessive
drinking during protracted abstinence. Much animal work to date has focused on the acute rein-
forcing effects of alcohol, binge-like alcohol seeking, and compulsive-like alcohol seeking during
acute withdrawal [Crabbe et al., 2011; Heilig et al., 2010]. However, very few studies focus on
protracted alcohol abstinence during withdrawal although it is a period highly relevant to human
relapse when acute signs of alcohol dependence have dissipated [Kreek et al., 2002]. These results
provide support for an integral role of the glucocorticoid system in mediating escalated alcohol
intake in animals with a history of alcohol dependence via alterations in key regions of reward and
stress circuitry.
In summary, we used a systems biology approach to produce a genome-wide transcriptional
regulatory network - or transcriptional-interactome - from gene expression profiles of brain re-
gions of the central reward and stress pathways in a rat behavioral model of dependence-associated
increased drinking. Using a strategy that infers transcription factor activity through the differen-
tial regulation of the direct transcriptional targets, we identified both region-specific and common
candidate transcriptional MRs governing the transition from moderate (nondependent) and exces-
sive (dependent) alcohol drinking brought about by a history of dependence. Results indicate that
analysis of interactomes is an effective strategy to identify key regulators of understand complex
psychiatric disorders such as alcoholism and support that master regulators identified like the glu-
cocorticoid receptor (Nr3c1) and Psip1 contribute to motivation for alcohol drinking in the setting
of dependence and are potential targets for novel medications for alcohol abuse.
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3.4 Materials and Methods
3.4.1 Statistical analysis
Behavioral data are expressed as mean and standard error of the mean (SEM). The data were an-
alyzed using analysis of variance (ANOVA) with treatment (0 vs. 30 µg) as the within-subjects
factor and group (dependent vs. nondependent) as the between-subjects factor. The post hoc com-
parisons were performed using Fisher’s Least Significant Difference (LSD) test. The accepted level
of significance for all tests was p < 0.05.
Promoter regions of the ARACNe predicted targets were defined as a 1000 bp region, 500 bp
upstream and downstream from the transcription start site of each gene. The test set was comprised
of 137 ARACNe-predicted targets of Nr3c1/GR, and the control set was comprised of 1000 genes
that were in the ARACNe network but not targets of Nr3c1/GR. The occurrence of the Nr3c1/GR
binding site was scored using the scoring method outlined in Conlon et al. [Conlon et al., 2003]
and significance was tested using Fisher’s exact test.
3.4.2 Gene expression profiles
Gene expression profiles were collected using the Affymetrix Rat Genome 230 2.0 GeneChip sys-
tem (31,099 probe sets). Expression measurements were normalized with gcrma [Wu et al., 2004],
which adjusts for background intensities in Affymetrix array data, including adjusting for opti-
cal noise and nonspecific binding. All array files were processed and normalized using R version




The normalized gene expression profiles were analyzed using the Cleaner Algorithm [Alvarez
et al., 2009]. The Cleaner Algorithm performs probe-remapping and probe-correlation analyses
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for assembly of informative, transcript-specific probe-clusters in Affymetrix expression microar-
rays. After applying Cleaner, the roughly 31,099 probesets that were originally on the microarray
platform were reduced to 7,019 highly-correlated probesets that mapped to 6,715 unique genes.
Cleaner R package (version 1.01) was applied to the expression profiles after normalization using
R version 2.15.1. The Cleaner-normalized gene expression profile used in our study is available
for download from figshare http://dx.doi.org/10.6084/m9.figshare.1154010.
3.4.4 Transcription Factor classification
To identify transcription factors (TFs), we selected the rat genes annotated as “transcription factor
activity” in Gene Ontology and the list of TFs from TRANSFAC[Wingender et al., 2000]. This
produced a final list of 898 TFs, from which 664 were present on the Cleaner-mapped expression
profile.
3.4.5 Signaling Molecule classification
To identify signaling molecules (Sigs), we selected the rat genes annotated in the GO Biolog-
ical Process database as: ‘signal transduction’ and in the GO Cellular Component database as
GO:0005622 – ‘intracellular’ or GO:0005886 – ‘plasma membrane’. This produced a final list of
2,842 genes from which 1,100 were present on the Cleaner-mapped expression profile.
3.4.6 ARACNe
To construct the CNS transcriptional-interactome, ARACNe was applied to the Cleaner-normalized
expression profile, as previously described [Alvarez et al., 2009]. ARACNe was run with the list of
664 known transcription factors, using adaptive partitioning algorithm, which selects the optimal
kernel width for calculating the MI threshold of a specified p-value. The MI threshold used by
ARACNe (MI ≥ 0.46108) corresponded to the p-value threshold of 10−8 after 100 bootstrap runs.
The resulting CNS transcriptional-interactome contained 78,090 statistically significant MIs be-
tween the 6,716 genes. The CNS transcriptional-interactome used in this study is available for
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download from figshare at (http://dx.doi.org/10.6084/m9.figshare.1154004)
To construct the CNS Signaling Molecule-Interactome, ARACNe was run using the same param-
eters as the CNS transcriptional-interactome using a list of 1,100 known signaling molecules. The
MI threshold used by the adaptive partitioning algorithm (MI ≥ 0.4543102) corresponded to the
p-value threshold of 10−8 after 100 bootstrap runs, and the resulting CNS Signaling Molecule-
Interactome contained 93,946 statistically significant MIs between 7,018 genes. The CNS Signal-
ing Molecule Interactome used in this study is available for download from figshare at: (http:
//dx.doi.org/10.6084/m9.figshare.1154006).
3.4.7 MARINa and Candidate Selection
Each TF with more than 25 targets in the CNS transcriptional-interactome was analyzed using
MARINa. GSEA was used to assess the enrichment of each TF’s regulon. As a reference, we
used a list of genes ranked with the absolute value of the t-statistics obtained by comparing de-
pendent and nondependent samples. The calculation of the enrichment of each TF produced a
list of candidate MRs in each of the sampled regions. MARINa was run with 10,000 probe-
shuffling permutations and each TF was given a p-value based on its normalized enrichment score
(NES) as described in Lefebvre et al. [Lefebvre et al., 2010]. Before running MARINa, the CNS
transcriptional-interactome was also trimmed at 100 interactions, which meant that for TFs that
had greater than 100 ARACNe predicted interactions, only the top 100 most-likely interactions
were considered in the calculation of the enrichment score. This was to address a bias in the
GSEA, which tends to give a higher score to TFs with larger regulons. Final Master Regulator
candidates were defined as TFs with a p-value < 0.01 according to their NES. Full tables of all
Master Regulator candidates for all sampled regions and comparisons, along with their associ-
ated Normalized Enrichment Scores (NES) and p-values, can be downloaded from figshare at:
http://dx.doi.org/10.6084/m9.figshare.1224365.
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3.4.8 Single-Sample MARINa and Activity Correlation Analysis
The relative activity of each transcription co-factor (Tfco) and signaling molecule was inferred for
each sample using a version of the MARINa algorithm [9] modified to allow signature analysis
on a sample-by-sample basis. Single-sample signatures were calculated by differential expression
analysis of the sample’s gene expression profile and the average of all gene expression profiles in
the same dataset. This analysis allows the inference of the relative activity of each transcriptional
regulator or signaling molecule in each sample, based on the relative change in expression of its
ARACNe-inferred targets. Specifically, we define the relative activity of a given regulator in a
specific sample as the normalized enrichment score (NES) computed by MARINa, based on its
gene expression signature. This single-sample MARINa analysis (ssMARINa) was implemented
as an R-system package, which is available for download from figshare http://dx.doi.org/
10.6084/m9.figshare.785718.
The correlation of MARINa activity was calculated between each signaling molecule or Tfco
that had greater than 25 targets in its regulon, and the significance of the correlation between each
pair was calculated by comparing to a null distribution generated by calculating the correlation
between random regulons of the same size.
81
Figure 3.1: Unsupervised hierarchical clustering of the microarray dataset used for the study
Similar transcriptional programs – as represented by their closeness in the cluster - were displayed
by Nac shell (NAcSh) and core (NAcC) sub-regions of the nucleus accumbens and by the extended
amygdala regions CeA (central nucleus of the amygdala) and dorsolateral and ventral BNST (dlB-
NST and vBNST, respectively). Also expectedly, the medial prefrontal cortex (mPFC), a cortical
region, clustered with the cortical-like basolateral nucleus of the amygdala (BLA).(Experiments
were performed by VC)
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(a) Top-25 results of MARINa for core of the nucleus accumbens on the Naive vs. NonDependent signature.
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(b) Top-25 results of MARINa for shell of the nucleus accumbens on the Naive vs. NonDependent signature.
(c) Top-25 results of MARINa for medial prefrontal cortex on the Naive vs. NonDependent signature.
84
(d) Top-25 results of MARINa for central amygdala on the Naive vs. NonDependent signature.
(e) Top-25 results of MARINa for basolateral amygdala on the Naive vs. NonDependent signature.
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(f) Top-25 results of MARINa for BNST ventral on the Naive vs. NonDependent signature.
(g) Top-25 results of MARINa for BNST dorsal on the Naive vs. NonDependent signature.
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(h) Top-25 results of MARINa for Ventral Tegmental Area on the Naive vs. NonDependent signature.
Figure 3.2: MARINa results for all regions in the Naive vs. NonDependent signature. The top-25
MR candidates are shown. The regions shown are a) Core of the Nucleus Accumbens (NAcC),
b) Shell of the Nucleus Accumbens (NAcSh), c) Medial Prefrontal Cortex (mPFC), d) Central
Amygdala (CeA), e) Basolateral Amygdala (BLA), f) BNST Ventral (vBNST), g) BNST Dorsal
(dlBNST), h) Ventral Tegmental Area (VTA). As with figure 2 in the main text, each row of the
plot shows the result of MARINa for each MR candidate. The p-value associated with each MR
candidate is shown on the left, and the differential expression (Exp) and the MARINA-predicted
differential activity (Act) for each MR are shown on the right in shades of red. The number on the
right side of the plot indicates the rank of differential expression (Exp) for each MR candidate. The
red lines in the middle of the plot indicate ARACNe predicted targets of each MR candidate. The
position of each line is determined by its differential expression, with more differentially expressed
genes being shown toward the left, and the less differentially expressed genes displayed toward the
right.
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(a) Top-25 results of MARINa for core of the nucleus accumbens on the NonDependent vs. Dependent
signature.
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(b) Top-25 results of MARINa for medial prefrontal cortex of the nucleus accumbens on the NonDependent
vs. Dependent signature.
(c) Top-25 results of MARINa for central amygdala of the nucleus accumbens on the NonDependent vs.
Dependent signature.
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(d) Top-25 results of MARINa for basolateral amygdala of the nucleus accumbens on the NonDependent
vs. Dependent signature.
(e) Top-25 results of MARINa for BNST ventral of the nucleus accumbens on the NonDependent vs. De-
pendent signature.
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(f) Top-25 results of MARINa for BNST dorsal of the nucleus accumbens on the NonDependent vs. Depen-
dent signature.
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(g) Top-25 results of MARINa for Ventral Tegmental Area on the NonDependent vs. Dependent signature.
Figure 3.3: MARINa results for all regions for the NonDependent vs. Dependent signature. The
top-25 MR candidates are shown. The regions shown are a) Core of the nucleus accumbens
(NAcC), b) Medial Prefrontal Cortex (mPFC), c) Central Amygdala (CeA), d) Basolateral Amyg-
dala (BLA), e) BNST Ventral (vBNST), f) BNST Dorsal (dlBNST), g) Ventral Tegmental Area
(VTA). Results of MARINa for core of the nucleus accumbens (NacC) are shown in Fig. 3.4 in the
main text.
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Figure 3.4: MARINa results showing candidate MRs driving the alcohol nondependence vs.
dependence differentially expressed gene signature in the core sub-region of the nucleus ac-
cumbens (NAc) sorted by their differential activity in alcohol dependence. Each row of the
plot shows the result of MARINa for each MR candidate. The p-value associated with each MR
candidate is shown on the left. The MARINa-predicted differential activity (Act), differential ex-
pression (Exp) and are shown on the right in shades of red: higher levels of Exp or Act are indicated
in dark red, while lower levels are indicated in light red or pink. The rank of Exp of each MR can-
didate is also shown on the right side of the plot. The red lines in the middle of the plot indicate
ARACNe predicted targets of each MR candidate. The position of each line on the horizontal axis
corresponds to its rank in the gene list, which is determined by its differential expression. More
differentially expressed genes being shown toward the left, and the less differentially expressed
genes displayed toward the right.
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Figure 3.5: Validation of ARACNe-predicted Nr3c1/GR regulon by siRNA-mediated down-
regulation of Nr3c1/GR followed by microarray analysis A) Nr3c1/GR was down-regulated
by use of a synthetic siRNA (Applied Biosystems) in the rat striatal medium spiny neuron cell
line M213 relative to an aspecific ‘scrambled’ siRNA (Scr.) control. B) We performed microarray
profiling and used gene expression differences between cells treated with siRNA to Nr3c1/GR
and the ‘scrambled’ siRNA control to interrogate the Nr3c1 regulon (i.e., targets of Nr3c1/GR
predicted by ARACNe) with the Gene Set Enrichment Analysis (GSEA) [Subramanian et al.,
2005]; n=4. Results showed enrichment of the genes in the Nr3c1/GR regulon among the genes
whose expression is affected by siRNA-mediated down-regulation of Nr3c1/GR in M213 cells
(GSEA result: NES=1.52, p < 0.006). C) Sequence logo of Nr3c1/GR binding site from JASPAR
database [Mathelier et al., 2013].(Experiments were performed by VC)
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Figure 3.6: Results of hierarchical clustering of MR candidates that were statistically significant
after p-value integration using Stouffer’s method for the Naive vs Nondep signature. The colors
represent the levels of inferred activities for the MRs, with the most intensely colored MRs being
the most active
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Figure 3.7: Results of hierarchical clustering of MR candidates that were statistically significant
after p-value integration using Stouffer’s method for the Nondependent vs Dependent signature.
The colors represent the levels of inferred activities for the MRs, with the most intensely colored
MRs being the most active.
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Figure 3.8: Targets of Nr3c1/GR as predicted by the ARACNe-generated transcriptional-
interactome Targets of Nr3c1/GR in the NAc core (A), shell (B), and VTA (C) differentially
regulated in the nondependent vs dependent signature. Targets of Nr3c1/GR in the CeA (D) in the
naive vs nondependent signature. For each comparison, the results of GSEA for Nr3c1/GR targets
in the corresponding signature are shown on the left and the Nr3c1/GR regulon on the right. In the
right panel, the distance between Nr3c1/GR and each target represents the degree of differential
expression in the signature. More differentially expressed genes are shown closer to Nr3c1/GR,
and less differentially expressed genes are shown further away. Genes in the leading edge of the
GSEA analysis are shown in red. These are ones that contribute most significantly to the enrich-
ment of Nr3c1/GR, and are the most strongly regulated targets of Nr3c1/GR. The GSEA panel on
the left shows the enrichment plot, NES and associated p-value. As with the regulon plot, the genes
in the leading edge are also shown in red.
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Figure 3.9: Results of MARINa analyses for Nr3c1/GR in alcohol naive vs. nondependent and
dependent alcohol self-administering rats Both the main stacked-column graph and line graph
inset show the differential activity of Nr3c1/GR in the control (alcohol naive), nondependent and
dependent alcohol self-administration groups. Nr3c1/GR differential activity is measured by the
normalized enrichment score (NES) in each region, calculated as the cumulative differential activ-
ity going from alcohol naive to nondependent and from nondependent to dependent. Nr3c1/GR is
activated in nondependent alcohol self-administering rats and increase to a lesser extent after the
transition to dependence. In other regions like the VTA and NAc core, Nr3c1/GR increases pro-
gressively from alcohol naive to nondependent alcohol self-administering to dependent rats, while
in the NAc shell, significant Nr3c1/GR activation is seen only after the transition to dependence.
The dashed red line of both plots indicate significantly increased differential activity of p<0.01
from alcohol naive control rats, which corresponds to an NES of approximately 2.33.
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Figure 3.10: Results of hierarchical clustering of MARINa-predicted activities for signaling
molecules that are also known modulators of Nr3c1/GR activity. Regions/conditions where the
genes were found to have increased activity are shown in shades of red. The genes shown were
found to have significant correlation with Nr3c1/GR activity across all the regions with a p-value
< 0.05.
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Figure 3.11: Results of hierarchical clustering of MARINa-predicted activities for TFs and co-TFs
that are also known modulators of Nr3c1/GR activity. Regions/conditions where the genes were
found to have increased activity are shown in shades of red. The genes shown were found to have
significant correlation with Nr3c1/GR activity across all the regions with a p-value < 0.05.
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Table 3.1: Number of Master Regulators (MRs) that were predicted in each region (p < 0.01). The
regions are nucleus accumbens core (NAcC), nucleus accumbens shell (NAcSh), ventral tegmen-
tal area (VTA), medial prefrontal cortex (mPFC), central amygdala (CeA), basolateral amygdala
(BLA), dorsal bed nucleus of the stria terminalis (dlBNST), and ventral BNST (vBNST). Naive :
alcohol naive control rats; NonDep : nondependent alcohol self-administering rats; Dep : depen-
dent alcohol self-administering rats
Comparison Region NAcC NAcSh VTA mPFC CeA BLA dlBNST vBNST
NaivevsNonDep MRs 28 56 51 148 42 15 44 51
NonDepvsDep MRs 17 30 56 14 28 39 48 15
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Table 3.2: Overlap of Master Regulators associated with the transition from alcohol naive to non-
dependent, or nondependent to dependent drinking between different regions. The table shows
the p-values associated with the overlap between different regions by Fisher’s exact test and the
number of overlapping Master Regulators (underneath). A) shows the results for Naive vs Non-
Dependent and B) shows the results for NonDependent vs Dep rats. Regions that had a significant
overlap (p < 0.01) are highlighted in bold
(a) Naive vs. NonDependent
NAcC NAcSh VTA mPFC CeA BLA dlBNST vBNST
NAcC
0.84 0.00 0.50 0.38 0.08 0.76 1.00
(1) (9) (5) (2) (2) (1) (0)
NAcSh
1.00 1.00 0.11 1.00 0.95 0.00
(0) (2) (5) (0) (1) (10)
VTA
0.12 0.21 1.00 0.73 1.00
(12) (4) (0) (2) (0)
mPFC
0.98 1.00 0.01 1.00











(b) NonDependent vs. Dep
NAcC NAcSh VTA mPFC CeA BLA dlBNST vBNST
NAcC
0.00 0.02 1.00 1.00 0.53 1.00 1.00
(6) (4) (0) (0) (1) (0) (0)
NAcSh
0.00 1.00 0.62 0.74 1.00 1.00
(8) (0) (1) (1) (0) (0)
VTA
0.21 0.01 0.43 0.01 1.00
(2) (6) (3) (8) (0)
mPFC
1.00 0.47 0.54 1.00












Table 3.3: MARINa results for Nr3c1/GR in all 8 profiled regions, for both alcohol exposed (Naive
vs NonDep) and addicted (NonDep vs Dep) signatures. For each region and comparison the table
shows the Normalized Enrichment Score (NES), a measure of TF activity given by MARINa, as
well as the associated p-value. The table also shows the Activity Rank of Nr3c1/GR, measured by
NES, and relative to all 898 TFs in the interactome, as well as the rank of differential expression
(DE Rank). A) shows the results of the Naive vs NonDep signature, and B) shows the results of
the Nondep vs Dep signature.
(a) Naive vs. NonDependent
Region Comparison NES Pvalue Activity Rank DE Rank
CeA Naive vs NonDep 3.0143333 0.0026 19 905
NAcC Naive vs NonDep 2.551565 0.0107 31 1030
MPF Naive vs NonDep 2.464279 0.0137 164 2089
VTA Naive vs NonDep 2.113606 0.0345 95 3198
BLA Naive vs NonDep 0.569967 0.5687 421 3050
NAcSh Naive vs NonDep 0.212906 0.8314 698 6816
vBNST Naive vs NonDep 0.121494 0.9033 776 6833
dlBNST Naive vs NonDep 0.065972 0.9474 796 5329
(b) NonDependent vs. Dep
Region Comparison NES Pvalue Activity Rank DE Rank
CeA Naive vs NonDep 4.648268 3.35E-06 5 394
NAcC Naive vs NonDep 3.491568 0.0005 1 544
MPF Naive vs NonDep 3.423246 0.0006 19 4087
VTA Naive vs NonDep 0.598959 0.5492 497 2778
BLA Naive vs NonDep 0.567610 0.5703 467 2281
NAcSh Naive vs NonDep 0.365819 0.7145 590 2035
vBNST Naive vs NonDep 0.127936 0.8982 792 5964
dlBNST Naive vs NonDep 0.041998 0.9665 812 5877
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Chapter 4
Assembly and Interrogation of Alzheimer’s
Disease Genetic Networks reveal Novel
Regulators of Progression
4.1 Introduction
Alzheimer’s disease (AD) is the most common form of dementia in the elderly and is projected to
affect over 100 million people worldwide by 2050 [WHO, 2011]. At the pathological level, it is
characterized by neuronal loss, extracellular plaques of Aβ and intracellular neurofibrillary tangles
composed of hyper-phosphorylated tau [Selkoe, 1991]. Currently there are no effective approaches
to prevent, cure or even slowdown the progression of the disease. Classical genetic and biochemical
approaches have implicated specific molecular pathways, such as those involved in APP process-
ing / Aβ generation [Wilson et al., 1999; Lefort et al., 2012], dendritic spine alterations [Moolman
et al., 2004; Pozueta et al., 2012], and inflammation [Wyss-Coray, 2006]. More recently, multiple
high-throughput technologies (transcriptomics, genomics, proteomics) have been applied and have
led to the discovery of new processes that are dysregulated in AD, such as those involved in pro-
tein misfolding, altered lipid and cholesterol homeostasis or oxidative stress [Loring et al., 2001;
Colangelo et al., 2002; Scheer et al., 2000; Liang et al., 2008; Noorbakhsh et al., 2009]. Yet, a com-
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prehensive understanding of AD pathogenesis remains elusive and will likely require an integra-
tive, regulatory network based analysis [Califano et al., 2012] of these distinct pathophysiological
processes to understand their inter-connectivity and their role in disease progression.
Systems Biology (SB) predicates the use of regulatory-model based methodologies, as opposed
to purely statistical association approaches, to support the integrative, unbiased interrogation of
large datasets to study their global behavior rather than studying the effect of individual genes. An
important limitation of classical approaches, relying on statistical association rather than causal
regulatory model analysis, is the inability to distinguish between primary causal disease drivers
and secondary (passenger) non-causal events. Indeed, as previously shown for the elucidation of
human malignancy drivers, these approaches are very effective at identifying both individual and
synergistic Master Regulators (MRs) genes that are both necessary and/or sufficient to induce
presentation of a specific pathophysiological phenotype, while discarding the majority of passenger
genes. These methods, for instance, have led to elucidation of experimentally validated drivers of
human disease and associated mechanisms, including the synergistic pair C/EBP and STAT3 in
the mesenchymal subtype of glioma [Carro et al., 2010], the triplet TLX1, TLX3, and RUNX1
in acute lymphoblastic leukemia tumorigenesis [Della Gatta et al., 2012], the pair FOXM1 and
MYB in formation of germinal centers [Lefebvre et al., 2010], and the AKT1 protein in driving
glucocorticoid resistance in T cell acute lymphoblastic leukemia [Piovan et al., 2013], among many
others.
In sharp contrast, model-based, SB approaches are just beginning to be applied to diseases of
the nervous system. In the context of AD, one study using “weighted gene co-expression network
analysis” found AD-related coexpression modules involved in immune response and in synaptic
and metabolic functions [Miller et al., 2008]. More recently, expression profiles from whole-brain
samples were used to construct a gene-regulatory network that implicated immune- and microglia-
associated genes in the progression of AD [Zhang et al., 2013]. However, the genetic determinants
and functional effectors of AD that are specific to the neural compartment of the brain, which is ul-
timately the one affected by the disease, remain elusive and have yet to be studied using a network
biology approach. Here, we propose that regulatory network methods that have produced signifi-
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cant discoveries in human neoplasia can be effectively applied to neurobiology and may provide
an important discovery tool for elucidating drivers and effectors of neurodegenerative processes.
In particular, we reasoned that interactome-based approaches using neuron-specific regulatory net-
works could help unveil novel genes contributing to AD pathogenesis in this cellular context.
Since an accurate, neuron-specific model of transcriptional regulation for AD is still elusive, we
used the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) to analyze
a large-scale gene expression profile dataset obtained from neurons isolated by laser-capture mi-
crodissection from human AD and control subjects [Gene Expression Omnibus dataset, GSE5281
and GSE9770 [Margolin et al., 2006; Liang et al., 2008; Liang et al., 2010]. This analysis yielded
a rich regulatory network representing the transcriptional layer of the human neuronal interactome
– i.e., the genome-wide repertoire of transcription-factor/target interactions that comprise the reg-
ulatory logic of neuronal cells. This regulatory network model was then interrogated by the Master
Regulator INference algorithm (MARINa) using gene expression signatures representing distinct
brain regions and AD stages to infer candidate MRs of clinically relevant phenotypes. Biochemical
and neuropathological validation studies suggest a role in AD pathogenesis for three novel MRs
inferred among the most significant ones by MARINa (YY1, p300 and ZMYM3), both at early and
late stages of disease progression. Taken together, these findings highlight novel specific patholog-
ical processes potentially leading to neuronal dysfunction and toxicity, such as an increased stabi-
lization of p53 and loss of acetylation homeostasis. Furthermore, they suggest that, similar to what
has happened in the study of human malignancies, unbiased analysis of genome-wide regulatory
networks can further our understanding of pathogenesis in AD and other neurodegenerative dis-
orders. A more detailed description of the experimental validation can be found in the manuscript
version of this chapter [Aubry et al., 2015], and the experimental results were performed by Dr.
Soline Aubry, who was cited as a co-first author in the manuscript.
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4.2 Results
4.2.1 Selection and assessment of the gene expression profiles dataset
To identify neuron-specific Master Regulators (MRs) as drivers of Alzheimer’s disease (AD) ini-
tiation and progression, gene expression signatures were generated from laser-captured neurons
from AD and control cases, encompassing both pathological and clinical phenotypes. Specifically,
we selected the Liang et al. dataset, which is comprised of gene expression profiles from laser-
capture microdissected (LCM) cortical neurons isolated from six anatomically and functionally
distinct postmortem human brain regions representing 14 controls, 10 non-demented individuals
with AD-type changes in their brains at autopsy (NDAD), and 34 demented individuals with the
histopathological confirmation of AD [Liang et al., 2008; Liang et al., 2010] (Table 4.3). To as-
semble the regulatory model (interactome), we used the full set of 193 gene expression profiles
representing the entorhinal cortex (EC), hippocampus (HIP), middle temporal gyrus (MTG), pos-
terior cingulate (PC), superior frontal gyrus (SFG) and visual cortex (VCX) of these individuals.
Cluster analysis revealed that samples from regions known to be severely affected in AD (e.g.,
HIP, EC or MTG) show tight clustering according to diagnosis whereas samples from regions rela-
tively less affected (i.e., VCX) do not cosegregate (Figure4.1 and Figure 4.2). Therefore, unbiased
clustering analysis confirms the reproducibility of clinically relevant molecular phenotypes and
suggests that patient stratification into these three diagnostic categories is biologically relevant,
as supported by common molecular features. Thus, the categories “Control”, “NDAD” and “AD”
were used to inform follow up analyses.
4.2.2 Construction of the human neuronal transcriptional interactome
The Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) [Margolin et al.,
2006; Basso et al., 2005] was previously developed to reconstruct the transcriptional regulatory
logic of specific cellular contexts. This logic comprises the set of regulatory targets, or regulon, of
each transcription factor (TF) or other transcriptional regulator of gene expression. For simplicity,
we will use the term TF to indicate both classes. Analysis of these 193 gene expression profiles by
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ARACNe yielded the first human causal transcriptional network for cortical neurons, representing
488,353 individual transcriptional interactions between 3,758 TFs expressed in this context and
their transcriptional targets.
4.2.3 Identification of candidate Master Regulators using MARINa
We then used the previously developed Master Regulator INference algorithm (MARINa) to in-
terrogate regulatory networks to identify candidate MR genes [Carro et al., 2010; Lefebvre et al.,
2010]. These represent regulators that are sufficient and/or necessary causal determinants of a spe-
cific phenotypic difference. MR candidates are identified by MARINa based on the enrichment
of their ARACNe-predicted targets in the differentially expressed genes of a specific phenotype,
similar to using a gene reporter assay approach to detect aberrant activity of a TF. The difference
is that instead of using a single reporter controlled by the promoter of a TF-target gene, we use
the expression of all the ARACNe-inferred targets of the TF. This allows identification of regu-
lators whose aberrant activity is post-translationally determined, which could not be identified by
differential expression, thus overcoming the limit of traditional analysis. MARINa analysis was
performed on 18 distinct gene expression profile signatures, representing three distinct phenotypic
differences (Control → NDAD, NDAD → AD, and Control → AD) across each of the six brain
regions. Candidate MRs were first selected based on their statistical significance and then sorted
by their Differentially Expressed Targets Odds Ratio (DETOR) [Lefebvre et al., 2010]. The latter
represents the density of targets in the leading edge of the GSEA analysis compared to the re-
maining range of expression and is a direct measure of the regulatory impact of the MR. These
analyses result in relatively small ranked-lists containing TFs that are most likely to be responsible
for the phenotypic difference in the brain region of interest. We also reasoned that candidate MRs
for a region specific signature should be independent from the number and specific selection of
the samples in the analysis. Thus, to filter out false positive MRs, we used bootstrapping on the 18
representative gene expression profile signatures, each time randomly sampling only 70% of the
total samples representing the signature, with replacement. Candidate MRs that failed to be iden-
tified in all 10 bootstrap runs were then considered false-positives and were excluded from further
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consideration. The results of the bootstrapping step on the count of candidate MRs are summarized
in Figure4.3. In the control v. NDAD phenotypic change, high numbers of candidates are found
in EC, HIP and MTG, which are regions showing early pathology in AD and are also affected in
aging to variable degrees. In contrast, in the control v. AD phenotypic change, we observe a posi-
tive correlation between the count of candidate MRs and the regional progression of AD. Finally,
comparing NDAD and AD allows for the highlighting of MRs mostly responsible for dementia
progression, as pathological hallmarks are already present in NDAD patients. Interestingly, the
highest counts are found in EC, MTG, PC and SFG and a very low count is found in HIP, showing
that in this region a small number of MRs are predicted to drive the phenotypic differences between
NDAD and AD patients. This is a common finding for this type of analysis, such that signatures
representing phenotype-relevant events produce a greater number of highly statistically significant
MRs than signatures that are not the result of specific regulatory events. To this extent, PC and
SFG are the two regions that differ significantly between the two phenotypic changes of interest
(control v. AD and control v. NDAD). As a negative control, VCX was found to show a significant
decrease in the number of candidate MRs in all three phenotypic changes, thus confirming its less
representative role in AD.
4.2.4 Selection of candidate MRs for biochemical validation and results of
experimental validation
In order to prioritize MRs for further biochemical validation, we made two assumptions. First,
we reasoned that AD should be reflected across a multitude of genetic programs that are either
brain region specific or common to multiple regions. However, we anticipated that focusing on
region-specific programs would lead to discovery of many idiosyncratic false-positive MRs (e.g.,
those regulating region-specific downstream programs from the true MRs or programs activated
within specific regions in response to neurodegeneration), whereas focusing on MRs conserved
across multiple regions should be more specific to bona fide upstream AD drivers. Hence, for each
phenotypic difference, we selected candidate MRs conserved across more than one region, thus
eliminating candidate MRs identified only in one region. Fig. 4.3 summarizes this analysis and
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Table 4.4 through Table 4.5 display the final lists of MRs on a region and transition-specific basis,
after this step.
Second, we assumed that candidate MRs regulating hippocampus-specific signatures would be
of particular relevance, as this region plays a central role in memory and is one of the first re-
gions affected in AD [Ball, 1977; Hyman et al., 1984; Small et al., 2011]. Two strategies were thus
followed in parallel: prioritizing candidates that are most highly ranked in HIP (strategy 1), or pri-
oritizing those that show up in the highest number of regions, including HIP (strategy 2). Through
these assumptions, we reduced our original MR set to about 20 candidates per strategy (Tables
4.1 and 4.2). Two of the highest ranked genes from each strategy, for which appropriate reagents
were available, were then selected for further validation in human brain tissue, by immunohisto-
chemistry and Western blot analyses. These include the E1A binding protein p300 (EP300), Ying
Yang 1 (YY1), the Zinc Finger, MYM-Type 3, (ZMYM3), and the Myocyte Enhancer Factor 2D
(MEF2D).
Finally, we asked whether the expression levels of these selected candidates in the laser-
captured neuron dataset correlated with that observed in mRNA obtained from whole human brain
tissue (Figure 4.4). For YY1, EP300 and ZMYM3, this analysis revealed an increase of mRNA
levels in AD cases compared to controls, suggesting that these two systems are comparable for
these genes and therefore justifying utilization of whole tissue for further analyses. MEF2D shows
no difference in the expression levels in the LCM dataset and the whole brain extracts, however,
this finding is compatible with our analysis, which focuses on inferred activity rather than differ-
ences in expression levels. When investigated further using immunoblot, immunohistochemistry
and binding assays, the experiments did not show consistent differences for both MEF2D and
phospho-MEF2D (unpublished data). Thus, only the results for YY1, EP300 and ZMYM3 are pre-
sented in the associated publication, with the experimental work performed by Dr. Soline Aubry.
A more detailed description of the experimental validation can be found in the manuscript version
of this chapter [Aubry et al., 2015].
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4.2.4.1 YY1 : YY1 transcription factor
YY1 is a ubiquitously expressed and highly conserved multifunctional transcription factor that can
either repress or activate gene expression depending on the cellular context [Thomas and Seto,
1999; Gordon et al., 2006]. Together, these results suggest an alteration of YY1 transcriptional ac-
tivity in AD brain through the modulation of full-length YY1 protein levels by proteolytic activity
and generation of potential dominant negative cleavage products.
4.2.4.2 EP300 : E1A binding protein p300
The p300/CREB-binding protein (CBP) co-activator family exerts its activity through various
mechanisms, including histone acetyltransferase (HAT) activity. Our results support the hypothesis
that p300 acetyltransferase activity is upregulated in AD brains, therefore modulating its transcrip-
tional activity. The results also support the hypothesis p300 and YY1 activities might converge to
increase p53 levels in AD brains, which correlates with previous reports [de la Monte et al., 1997].
4.2.4.3 ZMYM3 : zinc finger MYM-type containing 3
Finally, ZMYM3 is highly conserved among vertebrates, ubiquitously expressed in adult tissues,
but more abundant in the brain and predominantly located in the nucleus [van der Maarel et al.,
1996; Scheer et al., 2000]. Our immunohistochemistry and Western blot analyses corroborate these
findings and further indicate that ZMYM3 could emerge as a marker of disease severity. Further
studies will hopefully illuminate more details about the mechanisms modulating ZMYM3 activity
and its role in AD relevant pathways.
4.3 Discussion
Multiple pathological processes have been associated with Alzheimer’s disease (AD), highlight-
ing the complexity of the disease. Novel computational approaches have the potential to address
this complexity by enabling the interrogation of the system as a whole. Recent progress on the
reliability of high-throughput technologies combined with powerful computational and statistical
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analyses have now rendered such approaches feasible. In this study, we apply the ARACNe and
MARINa algorithms to Alzheimer’s disease and examine their utility by subsequent biochemical
and histopathological analyses in human postmortem tissue. Our approach is free of in vitro and an-
imal model bias and is driven by regulatory models and disease-relevant signatures obtained exclu-
sively from the neural compartment of primary human samples, isolated by LCM. The latter avoids
significant bias due to the cellular heterogeneity that is inherent in approaches based on whole brain
transcriptome profiling. Indeed, we and others have reported that transcriptional regulatory models
are highly divergent in different cellular lineages and have advocated the use of context-specific
regulatory models, dissected from homogenous cellular populations. Our methodology relies on
the identification of candidate genes based on their inferred protein activity, rather than their ex-
pression levels, and on their direct causal relevance in implementing the observed disease-specific
signatures. This represents a novel strategy in the effort to pinpoint genes whose activity drives
disease progression according to various post-translational mechanisms, e.g., proteolytic regula-
tion for YY1, post-translational modification for p300 and modulation level for ZMYM3. Two of
the lead candidate MRs found by our computational approach, YY1 and ZMYM3, have not been
previously implicated in AD, and our analysis has provided a number of additional candidates that
we plan to investigate in follow-up studies.
The importance of this approach is heightened by the limitation of current animal models of
AD, which do not replicate the full pathological picture and are therefore of limited usage for bio-
chemical studies and drug discovery. In this regard, our Systems Biology (SB) approach provides
a dynamic interpretation of the static postmortem state. Increasing the size of the dataset, by in-
cluding, for example, additional tissue samples from younger AD patients would have the potential
to enrich the analysis and identify candidate genes active at earlier stages of disease progression.
The studies reported here were designed as “proof of principle” and we used specific assumptions
and filters to identify a small subset of candidate MRs for experimental validation. This suggests
that alternate filters, such as filtering by synaptic proteins rather than on brain regions, will also
be effective in unveiling additional candidate MRs. Finally, we wish to emphasize that the hu-
man neuronal interactome generated in this study is not specific to AD and can be interrogated
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using data obtained from a broad range of neurological and psychiatric diseases, allowing for the
identification of neuron-specific MRs in these disorder.
These analyses have been performed by combining the effect of different genetic backgrounds
with the variability induced by the analysis of multiple brain regions. This is consistent with pre-
vious work in prostate cancer [Aytes et al., 2014] where variability induced by different genetic
backgrounds was combined with variability resulting from pharmacological perturbation without
introducing artifacts or false positives. In the original design of the MARINa algorithm [Lefebvre
et al., 2010] we also addressed the issue of potential confounding issues resulting from the intro-
duction of samples that may represent hierarchical structures in tissue stratification. Specifically,
we showed that, as long as the strongly correlated samples (e.g., those coming from the same tumor
subtypes) represent no more than 20% of the data, there was virtually no difference in the results
of the analysis when the samples are removed from the network inference and used only in the
MARINa analysis. Taken together these works support the results of this study.
Our findings also suggest that an SB approach may be a valuable addition to conventional
methods for the study of neurodegenerative phenotypes, by revealing candidate MRs acting at
different stages of disease progression. It is also interesting to note that two of our MRs are not
affected by Aβ, suggesting that the direct analysis of human tissue will detect alterations that may
not be found in the commonly used mouse models of AD. By assessing candidate MRs that are
highly enriched in the hippocampus, we found MRs that are dysregulated in relatively early stages,
i.e., YY1 and p300. By assessing candidate MRs that do not necessarily display a high enrichment
score in the hippocampus, but are significantly ranked in the highest number of regions, we found
MRs exhibiting biochemical changes in severe cases only, i.e., ZMYM3. We hypothesize that
future studies analyzing expression profiles from subjects with prodromal AD or mild cognitive




In summary, we applied a Systems Biology approach to a set of gene expression profiles from
laser-captured neurons of human brains and generated the transcriptional component of a human
neuronal interactome. The interactome is by itself an invaluable resource that can be interrogated
in future studies to unveil candidate MRs playing a role in other neurological contexts or at dif-
ferent stages of disease progression by inputting relevant gene expression profiles. Interrogating
this interactome in the context of AD provided an unbiased list of candidate MRs potentially
playing a role in the disease progression. We have evidence to support that three of the selected
candidates exhibit dysregulated behaviors in human AD autopsy brain tissue, but further valida-
tion in cellular and animal models is necessary to understand their role in the pathology. How-
ever, these dysregulations highlight specific pathological processes that can be further studied. On
one hand, both p300 and YY1 activities lead to an increased stabilization of p53, thus appear-
ing as a potential downstream effector of both MRs and as a main player in neurodegenerative
processes. On the other hand, all studied MRs are involved in HAT/HDAC activity: p300 is a
HAT, YY1 activity is regulated by various HATs/HDACs such as p300 [Thomas and Seto, 1999;
Sankar et al., 2008] and ZMYM3 is a component of a HDAC-containing complex [Hakimi et al.,
2003]. These results support the hypothesis that a loss of acetylation homeostasis in AD could
explain neuronal dysfunction and toxicity [Selvi et al., 2010].
4.5 Materials and Methods
4.5.1 Dataset Processing and Normalization
The analysis was performed on the Liang et al. dataset [Liang et al., 2008; Liang et al., 2010].
The dataset was downloaded from the Gene Expression Omnibus website, reference GSE5281 and
GSE9770, and contained 193 samples corresponding to six regions obtained from 14 controls, 10
NDAD individuals and 34 demented individuals with the histopathological confirmation of AD.
The gene expression profiles in the dataset were collected using the Affymetrix Human Genome
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U133 Plus 2.0 Array GeneChip R© system (54,675 probe sets). Expression measurements were nor-
malized with gcrma [Wu et al., 2004], which adjusts for background intensities in Affymetrix array
data, including adjusting for optical noise and non-specific binding. The array files were processed
and normalized using R version 2.15.1.
4.5.2 Hierarchical Clustering
Clustering analysis was performed using BRB-Array tools version 4.3.2. Out of the 54,675 probe-
sets that were present on the array, 23,594 probesets that passed the BRB-Array tools filters were
used to perform the clustering. The arrays were normalized using a modified version of RMA,
which uses a random subset of the arrays to generate the normalization and probset summary val-
ues. Centered (Pearson) correlation was used as the distance metric, and the average distances
between all pairs of probesets that had an associated p-value of < 0.01 were used to build the
clusters.
4.5.3 ARACNe
Context specificity is critical to reconstruct the transcriptional regulatory logic as TF regulons
are highly context dependent. The ability to accurately reconstruct such logic using ARACNe is
predicated on the availability of large gene expression profiles datasets, including more than 100
samples, which represent either natural or perturbation-induced genomic variability of the context
of interest. For the reconstruction of the human neuronal interactome, we assumed that differ-
ent individuals represented sufficient naturally occurring genotypic variability, while the different
regions represented sufficient variability associated with microenvironment related signals, thus
resulting in an interactome representing an accurate estimate of the overall variability of cortical
neuron gene expression. This assumption is supported by the t-SNE [van der Maaten and Hinton,
2008] results on all samples, which show separation between regions that are severely affected in
AD, as well as high variability between regions overall (Figure 4.5). Thus, in contrast to traditional
approaches, where one attempts to minimize variability by profiling several biological replicates,
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ARACNe benefits from inter-sample variability as this allows for a more accurate inference of
transcriptional interactions by taking into account inter-sample transcriptional regulatory differ-
ences. In contrast, the signatures used to interrogate the interactome require significant phenotypic
specificity and benefit from replicate samples. To construct the neuronal transcriptional network,
ARACNe was applied to the set of 193 gcrma-normalized expression profiles using the adaptive
partitioning algorithm, which selects the optimal kernel width for calculating the Mutual Informa-
tion (MI) threshold of a specified p-value. The MI threshold used by ARACNe (MI >= 0.2185)
corresponded to the p-value threshold of 10-7 after 100 bootstrap runs. The resulting central ner-
vous system (CNS) Interactome contained 488,353 statistically significant MIs between the 3,758
TFs and 38,045 genes.
4.5.4 MARINa and Candidates Selection
MARINa was used to infer MRs that drive the transition between Control and AD samples, as
defined by pathological and clinical characterization. Given a regulatory network model, MARINa
requires a relatively small numbers of gene expression profiles (N >= 6) representing each pheno-
type of interest in a specific transition (e.g., 6 gene expression profiles for NDAD and 6 for AD), to
identify the candidate MR genes. For each phenotype transition of interest (e.g., Control→ AD in
HIP), we first generate the gene expression profile signature, defined as all genes represented on the
specific microarray platform, ranked from the most underexpressed to the most overexpressed in
the disease phenotype compared to Control samples, as determined by a t-test. MRs are then iden-
tified as the TFs with the highest likelihood of implementing the specific signature based on the
regulatory mode, i.e., those whose ARACNe-inferred targets (i.e. TF-regulon) are most enriched
in differentially expressed genes in the gene expression profile signature. For instance, a positive
MR (whose activation drives the transition) would have its positively regulated targets highly en-
riched in overexpressed genes and repressed targets highly enriched in under expressed genes in
the signature of interest. The opposite would be true for negative MRs (whose inactivation drives
the transition). Such enrichments can be effectively assessed by a multi-tail extension of the Gene
Set Enrichment Analysis (GSEA) [Subramanian et al., 2005]. Thus, importantly, identification of
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candidate MRs is based on the expression of their ARACNe-inferred targets rather than on their
own change in expression level.
Master Regulator INference analysis (MARINa) was used to analyze each TF with more than
20 targets in the human neuronal transcriptional network, with GSEA [Subramanian et al., 2005]
used to assess the enrichment of each TF’s set of predicted targets. As a reference, we used the
set of genes on the expression profile, ranked by their t-statistic calculated by comparing the can-
didate phenotypic transition of interest (e.g., Control→ AD in HIP). P-values were computed by
performing 1,000 sample-shuffling permutations and each TF was given a p-value based on its en-
richment score according to GSEA. Shadow Analysis was performed as described in Lefebvre et al
[Lefebvre et al., 2010], to eliminate false positive representing TFs with substantially overlapping
programs with bona fide MRs but unlikely to drive the signatures of interest. Master Regulator
candidates (i.e., TFs with p <0.01, not removed by Shadow Analysis) were sorted by their Dif-
ferentially Expressed Targets Odds Ratio (DETOR) score, as given by Master Regulator Analysis
[Lefebvre et al., 2010]. The counts of candidate MRs obtained in each region at this step can be
found in Figure 4.3.
4.5.5 Transcription Factors classification
To identify transcription factors (TFs), we selected the mouse genes annotated as “transcription
factor activity” in Gene Ontology and the list of TFs from TRANSFAC. This produced a final list
of 1,794 TFs, which mapped to 3,758 probesets on the gcrma-normalized expression profile.
4.5.6 Specificity-weighted GSEA and Bootstrapping
To further classify the MRs that were most relevant for disease outcome, we applied specificity-
weighted GSEA in combination with bootstrapping of the samples. Specificity-weighted GSEA is
an alternative method that can be used to predict master regulator candidates. Similar to MARINa,
specificity-weighted GSEA begins by measuring the enrichment of differentially expressed targets
for each TF. However, in calculating the enrichment score for each TF and its target, it takes
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into account the specificity of interaction between TF and its target, i.e. the total number of TFs
regulating the target according to the neuronal transcriptional network. The original GSEA paper
by Subramanian [Subramanian et al., 2005] describes the calculation of the Enrichment Score (ES)
in the following way, with ES being the maximum deviation from zero of Phit − Pmiss
1. Rank order N genes on the microarray platform to form L = g1...gN according to the t-score
of their differential expression between phenotype 1 and phenotype 2
2. For each TF being tested by specificity-weighted GSEA, calculate the fraction of genes in S
(“hit”, or targets of the TF according to the neuronal transcriptional network) weighted by




























Where Tj is the number of TFs that regulate gene Rj . The application of this equation results
in more conservative estimate of the enrichment score of each TF. In addition, the method rewards
TFs that have specific targets.
In order to select for highly enriched MR candidates, 10 iterations of specificity-weighted
GSEA was run with bootstrapping. Each bootstrap run was performed using 70% of samples in
each class (random subset with replacement) and 1,000 sample-shuffling permutations. Each TF
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was given a p-value based on its enrichment score according to specificity-weighted GSEA, and
the results were sorted by their DETOR score [Lefebvre et al., 2010]. Eventually we only selected
MR candidates that had a p-value < 0.01 according to specificity weighted GSEA in 10 out of
10 bootstrap runs. The use of bootstrapping and specificity-weighted GSEA allowed us to identify
two groups of candidate MRs: those whose predicted activities were highly enriched regardless
of which individual samples were used (“stable” candidates), and another group whose predicted
activities showed significant fluctuations depending on which individual samples were used (“un-
stable” candidates). Number of stable candidate MRs in each of the regions and comparisons, as
well as their effect on the final results can be found in Figure 4.3.
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Figure 4.1: Cluster dendrograms for hippocampus and visual cortex samples Bioinformatic
analysis reveals a high degree of clustering of Alzheimer disease (AD), non-demented AD (NDAD)
and control (C) in the hippocampus but not the primary visual cortex. Dendrogram showing clus-
tering of (A) the hippocampus and (B) primary visual cortex samples using centered correlation
and average linkage.
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Figure 4.2: Dendrograms showing clustering of samples for (A) enthorinal cortex, (B) middle
temporal gyrus, (C) posterior cingulate and (D) superior frontal gyrus using centered cor-
relation and average linkage C = control; NDAD = non-demented Alzheimer’s disease; AD =
Alzheimer’s disease.
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Figure 4.3: Count of candidate MRs per region and per comparison groups after each com-
putational analysis. Master Regulator Inference analysis (MARINa) reveals different numbers of
candidate Master Regulators (MRs) by brain region and comparison group. Count of candidate
MRs in (A) control v. Alzheimer’s disease (AD), (B) control v. non-demented Alzheimer’s disease
(NDAD) and (C) non-demented Alzheimer’s disease (NDAD) v. Alzheimer’s disease (AD) after
each analysis. EC = entorhinal cortex, HIP = hippocampus, MTG = middle temporal gyrus, PC =
posterior cingulate, SFG = superior frontal gyrus, VCX = visual cortex.
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Figure 4.4: Fold changes of mRNA levels between Alzheimer’s disease (AD) and controls are
similar when comparing data from laser-captured neurons in middle temporal gyrus (MTG)
and whole tissue extracts from the temporal neocortex (BA38) The Q-PCR analysis performed
on whole tissue extracts from AD (n = 11) and controls (n = 8) shows a significant increase in
mRNA level for YY1 (p = 0.04) and ZMYM3 (p = 0.009), a non-significant increase for EP300 (p
= 0.06) and a stable level for MEF2D, which are comparable to those observed in the laser-captured
neuron dataset. Statistical analyses were performed using the Student’s t-test.(Experiments were
performed by SA)
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Figure 4.5: The results of t-SNE on the principle components of gene expression in the AD
dataset Prior to applying the t-SNE method, principle component analysis was performed on the
expression data to extract the most informative features. The first 20 principle components were
used to run t-SNE. As the plot shows, regions severely affected in AD, such as EC and HIP, show
separation according to phenotype, whereas the rest of the samples show more variability. These
results supported our assumption that the samples in the dataset exhibited the variability we needed
to be able to accurately reconstruct the neuronal interactome using ARACNe.
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Table 4.1: List of candidate MRs for each comparison (Control v. NDAD and Control v. AD) in
strategy 1 (highly ranked in HIP).
Gene Name Probe Number NES Odds Ratio
Alzheimer’s disease
EP300 202221 s at 1.98 151.63
YY1 201901 s at 1.97 133.82
BUD31 205690 s at -1.88 94.58
ILF3 208930 s at 2.09 65.61
TRIM27 212118 at -1.88 56.33
ZDHHC21 233216 at 1.99 55.42
ZFC3H1 213065 at -1.96 47.31
ZNF75A 227670 at -1.89 37.53
ZNF410 202010 s at -1.89 33.94
ZNF451 215012 at 1.89 27.98
Non-demented Alzheimer’s disease
KDM5A 215698 at 1.98 191.76
TFAM 203176 s at 2.12 183.43
MEF2A 208328 s at 2.00 104.84
ZNF800 227101 at 2.00 102.54
ZFAND5 217741 s at 2.00 75.42
THRA 204100 at -1.88 72.81
ZCCHC2 219062 s at 2.05 40.86
EP300 202221 s at 1.90 38.00
NFIA 224976 at -1.90 36.78
BCL11A 219498 s at 1.99 36.54
BCL11A 222891 s at 1.97 30.92
SALL2 213283 s at -1.97 25.00
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ZBTB16 205883 at -1.96 23.91
THRA 35846 at -1.99 21.93
MR master regulator, NES normalized enrichment score, HIP hippocampus, AD Alzheimer’s dis-
ease, NDAD non-demented Alzheimer disease
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Table 4.2: List of candidate MRs for each comparison (Control v. NDAD and Control v. AD) in
strategy 2 (enriched in HIP and at least 2 other regions)
Gene Name Probe Number # regions NES(HIP) Odds Ratio(HIP)
Alzheimer’s disease
THRA 1316 at 4 1.97 105.009
BBX 223134 at 4 1.97 55.002
NFAT5 208003 s at 4 1.98 138.656
EP300 202221 s at 3 1.98 151.633
ZFR 201856 s at 3 1.99 141.377
ZNF710 39891 at 3 1.99 134.643
ZNF609 212620 at 3 1.98 118.809
ZNF785 1554770 x at 3 1.89 117.578
ZNF562 219163 at 3 1.91 109.206
KHSRP 204372 s at 3 1.94 102.221
BUD31 205690 s at 3 -1.88 94.581
PHF3 215718 s at 3 1.99 82.351
ZNF264 205917 at 3 1.90 60.619
TRIM27 212118 at 3 -1.88 56.330
ZDHHC21 233216 at 3 1.99 55.417
LMO3 204424 s at 3 -1.94 34.285
ZCCHC17 223107 s at 3 -1.83 31.673
Non-demented Alzheimer’s disease
ZMYM3 1554171 at 6 1.97 45.92
MEF2D 225641 at 5 2.00 74.56
RBPJ 211974 x at 5 -2.01 20.13
THRA 35846 at 4 -1.99 21.93
ZCCHC2 219062 s at 4 2.05 40.86
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ZNF780B 244818 at 3 1.88 188.16
ZDHHC21 233216 at 3 1.95 40.79
NFIA 224976 at 3 -1.90 36.78
BCL11A 219498 s at 3 1.99 36.54
ZNF320 229614 at 3 1.94 33.66
CTNP1 213980 s at 3 -2.29 8.96
MR master regulator, NES normalized enrichment score, HIP hippocampus, AD Alzheimer’s dis-
ease, NDAD non-demented Alzheimer disease
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Table 4.3: Summary of the number of gene expression profiles used for computational analysis
based on clinical and pathological classification
Control NDAD AD
Age of death (yr) 79.8 ± 9.1 86.6 ± 5.3 79.9 ± 6.9
CERAD Infrequent Moderate/ Moderate/
(neuritic plaque density) Frequent Frequent
Braak Stage I - II II - IV V - VI
Clinical diagnostic Non-demented Non-demented Demented
EC 11 6 9
HIP 13 6 10
MTG 11 6 16
PC 13 5 9
SFG 10 6 23
VCX 12 5 19
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Table 4.4: List of candidate MRs for each comparison (Control versus NDAD, Control versus AD,
and NDAD versus AD) in HIP after bootstrap and overlap.
Gene Name Probe Number NES Odds Ratio Other Regions
Control versus Affected
KDM5A 226367 at 2.092 712.302 MTG
ZNF131 221842 s at 2.002 278.485 MTG
PHF3 217951 s at 1.997 216.843 MTG
UBN1 209088 s at 2.008 171.193 MTG
ZNF510 206053 at -1.972 163.245 SFG
EP300 202221 s at 1.983 151.633 MTG, SFG
ZC3H11A 205787 x at 1.963 147.34 EC, MTG
KLF9 203542 s at 2.02 143.819 MTG
ZFR 201856 s at 1.987 141.377 MTG, SFG
NFAT5 208003 s at 1.976 138.656 PC, MTG, SFG
ZNF710 39891 at 1.989 134.643 PC, MTG
YY1 201901 s at 1.965 133.824 MTG
ZNF609 212620 at 1.984 118.809 MTG, SFG
ZNF785 1554770 x at 1.887 117.578 MTG, SFG
ZNF671 219849 at -1.919 109.466 PC
ZNF562 219163 at 1.914 109.206 MTG, SFG
THRA 1316 at 1.969 105.009 PC, MTG, SFG
ZFP91 224631 at 1.96 103.026 MTG
KHSRP 204372 s at 1.937 102.221 PC, MTG
ZBTB7A 213303 x at 2.059 98.331 MTG
BUD31 205690 s at -1.876 94.581 PC, MTG
ZNF777 1553172 at 1.98 92.025 MTG
PHF3 215718 s at 1.999 82.351 MTG, SFG
ZNF319 228460 at 1.992 80.796 MTG
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BBX 232008 s at 1.943 72.571 MTG
ILF3 208930 s at 2.09 65.609 MTG
ZNF264 205917 at 1.9 60.619 MTG, SFG
TRIM27 212118 at -1.877 56.333 PC, MTG
SOX5 207336 at 2.042 55.583 MTG
ZDHHC21 233216 at 1.988 55.417 MTG, SFG
BBX 223134 at 1.967 55.002 EC, MTG, SFG
IKZF4 226759 at 1.895 53.461 SFG
ZFC3H1 213065 at -1.959 47.312 PC
ZBED5 218263 s at -1.81 42.383 PC
FOXK2 226224 at -1.871 41.367 PC
ZNF75A 227670 at -1.893 37.534 PC
LMO3 204424 s at -1.937 34.285 PC, MTG
ZNF410 202010 s at -1.885 33.943 PC
ZCCHC17 223107 s at -1.829 31.673 PC, MTG
ZNF266 214686 at -1.931 29.573 PC
ZNF561 235200 at 2.017 28.886 MTG
GZF1 225884 s at -1.808 28.467 PC
ZNF451 215012 at 1.89 27.976 MTG
NDAD versus Affected
TSC22D4 208104 s at 1.806 46.219 EC, MTG, SFG
ZNF358 219379 x at 1.837 45.177 EC, PC, MTG,
SFG, VCX
TFE3 212457 at 1.881 38.376 MTG, SFG, VCX
NFIC 213298 at 1.902 32.403 EC, MTG, SFG,
VCX
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HEY2 222921 s at 1.798 31.96 EC, MTG, SFG
WIZ 52005 at 1.83 31.511 MTG, SFG, VCX
HIF3A 219319 at 1.774 31.032 EC, MTG, SFG,
VCX
NFIC 206929 s at 1.824 30.317 EC, MTG, SFG,
VCX
ZFYVE20 1553570 x at 1.839 28.904 EC, MTG, SFG,
VCX
ILF3 217804 s at 1.938 27.087 VCX
MAZ 212064 x at 1.921 27.083 EC, PC, SFG,
VCX
NFIA 224970 at 1.801 25.591 EC, MTG, SFG,
VCX
HDGF 200896 x at 1.901 25.178 EC, MTG, SFG,
VCX
NFIA 226806 s at 1.783 24.151 EC, MTG, SFG,
VCX
ZBTB4 227047 x at 1.942 23.072 SFG, VCX
NR2F6 209262 s at 1.86 22.529 MTG, VCX
TCF7L1 221016 s at 1.847 21.478 EC, MTG, SFG,
VCX
SIX5 229009 at 1.736 20.552 EC, SFG, VCX
ZDHHC21 229240 at -1.701 19.501 PC, MTG, VCX
BAZ1B 213336 at 1.877 18.534 EC
USF2 202152 x at 1.863 16.867 EC, SFG, VCX
NR2F1 209506 s at 1.81 16.799 MTG, VCX
TFEB 50221 at 1.773 16.693 PC, SFG
ZNF385A 226111 s at 1.81 13.899 EC, PC
132
Control versus NDAD
KDM5A 215698 at 1.976 191.759 MTG
ZNF780B 244818 at 1.877 188.161 PC, VCX
TFAM 203176 s at 2.118 183.427 MTG
ZBED1 203043 at -2.018 173.732 VCX
ZFR 33148 at 2.12 162.078 MTG
SNAPC1 205443 at 2.048 152.918 MTG
IKZF4 226759 at 1.871 151.77 MTG
ZNF638 1554249 a at 2.04 144.44 MTG
ZNF589 1569108 a at 1.885 140.579 MTG
ZNF770 238687 x at 2.066 127.226 MTG
BCLAF1 214499 s at 2.02 124.584 MTG
MLL 212079 s at 2.002 106.517 MTG
MEF2A 208328 s at 2.002 104.843 MTG
ZNF800 227101 at 2.003 102.538 MTG
BCLAF1 201083 s at 2.04 88.684 MTG
ZNF264 205917 at 1.874 83.076 MTG
ZFP14 232911 at 1.87 80.967 MTG
ZFAND5 217741 s at 1.996 75.424 MTG
MEF2D 225641 at 2.004 74.555 EC, PC, MTG,
VCX
THRA 204100 at -1.884 72.805 VCX
KDM5B 201548 s at 2.053 72.147 MTG
ZMYM2 210282 at 2.087 68.367 MTG
ATF4 200779 at -1.902 67.54 VCX
RUNX1T1 205529 s at 1.976 64.892 MTG
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KLF9 203542 s at 1.938 53.226 MTG
NCOA1 210249 s at -1.967 50.224 VCX
ZBTB38 1558733 at 1.966 50.108 MTG
RUNX1T1 205528 s at 2.025 48.329 MTG
ZMYM3 1554171 at 1.967 45.918 EC, PC, MTG,
SFG, VCX
ILF3 217804 s at -1.943 45.026 MTG
LHX2 211219 s at -1.873 42.066 EC
ZNF587 231820 x at 1.902 41.494 MTG
ZCCHC2 219062 s at 2.048 40.86 PC, MTG, VCX
ZDHHC21 233216 at 1.945 40.791 MTG, SFG
ZNF319 228460 at 2.046 40.054 MTG
NCOA1 209107 x at -1.904 39.312 VCX
EP300 202221 s at 1.895 38.002 MTG
NFIA 224976 at -1.903 36.78 PC, VCX
BCL11A 219498 s at 1.993 36.541 PC, MTG
ZNF777 1553172 at 2.113 36.529 MTG
LZTS1 47550 at 2.054 34.476 MTG
ZNF320 229614 at 1.941 33.659 EC, MTG
ZDHHC21 243835 at 2.026 32.69 MTG
ZFYVE21 224445 s at -1.97 31.31 PC
BCL11A 222891 s at 1.972 30.924 MTG
TSC22D2 204094 s at 2.039 25.448 MTG
GATAD2B 225393 at 2.108 25.185 MTG
SALL2 213283 s at -1.97 24.997 EC
ZBTB16 205883 at -1.962 23.907 VCX
ZFAND3 218020 s at -2.098 22.06 PC
THRA 35846 at -1.986 21.925 EC, PC, VCX
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RBPJ 211974 x at -2.009 20.133 EC, PC, MTG,
VCX
ZC3HAV1L 228280 at 1.941 13.91 MTG
CTBP1 213980 s at -2.297 8.956 EC, PC
MR master regulator, NES normalized enrichment score, HIP hippocampus, AD Alzheimer’s dis-
ease, NDAD non-demented Alzheimer’s disease
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Table 4.5: Summary of brain tissue used for immunoblots and immunohistochemistry.
Control moderate AD AD
Age of death (yr) 82.6 ± 1.8 86.4 ± 2.2 82.4 ± 2.5
Clinical diagnostic No Yes Yes
CERAD A B C
(neuritic plaque density) (Sparse) (Moderate) (Frequent)
Braak stage III-IV V-VI VI
NFT frequency None Low High
(frontal/parietal cortex) (3-6 NT/100x) (≥ 7 NT / 100x)
CERAD consortium to establish a registry for Alzheimer’s disease, NFT neurofibrillary tangles
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Chapter 5
Identification of Neurodegenerative Factors
in Parkinson’s Disease Using
Translatome-Regulatory Network Analysis.
5.1 Introduction
Neurodegenerative diseases are debilitating disorders of the central nervous system (CNS) char-
acterized by the progressive loss of distinct neuronal cell populations. Common examples of such
diseases include Parkinson’s disease (PD), Alzheimer’s disease, amyotrophic lateral sclerosis and
spinal muscular atrophy. Numerous questions exist regarding the molecular mechanisms under-
lying neuronal degeneration, and the identification of these pathways has proven challenging. As
such, effective treatments are scarce. Discovery of the intrinsic factors that determine the survival
of neurons and mediate their degeneration would have far-reaching implications for the develop-
ment of neuroprotective strategies and the therapeutic management of these disorders.
Gene expression profiling is now routinely used to study the phenotypic changes in neurons
resulting from pathological events. However, the cellular heterogeneity of the mammalian CNS
significantly limits the usefulness of whole tissue for the generation of gene expression profiles
specific to the neurons susceptible to degeneration. Investigations based on the isolation of these
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neurons by laser capture microdissection can be cell type-specific, but they rely on the extraction
of total cellular RNAs and are not limited specifically to the mRNAs that are translated into pro-
teins. Molecular profiling of distinct cell populations in vivo has recently been described using
translating ribosome affinity purification (TRAP). TRAP utilizes the targeted expression of ei-
ther enhanced green fluorescent protein (EGFP) fused to ribosomal protein L10a or hemagglutinin
fused to ribosomal protein L22 to tag ribosomes and purify translated messages from the cells of
interest [Heiman et al., 2008; Doyle et al., 2008; Sanz et al., 2009]. However, the application of
this methodology to the molecular characterization of vulnerable neurons in the context of vari-
ous neurodegenerative diseases has been hampered by the limited availability of suitable transgenic
TRAP mouse lines. Moreover, TRAP does not improve the downstream analysis and interpretation
of gene expression data. Comparing the molecular signatures of cells across various experimental
conditions typically identifies a large number of genes whose transcript levels differ significantly.
Despite the availability of several bioinformatic tools for the functional analysis of large expression
datasets such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Database for An-
notation, Visualization and Integrated Discovery (DAVID)[Kanehisa, 1997; Huang da et al., 2009b;
Huang da et al., 2009a], the prioritization of promising differentially expressed candidate genes
has unfortunately remained difficult. Additionally, conventional analyses do not facilitate the iden-
tification of the upstream regulators that induce the gene expression changes associated with a
pathological phenotype. These shortcomings further hinder the discovery of novel key molecular
markers associated with neuronal degeneration.
Using PD as an example, we developed a strategy for the identification of genes that mediate
the response of mature neurons to degenerative insult. The motor manifestations associated with
PD are primarily linked to the progressive loss of midbrain dopaminergic (DA) neurons in the sub-
stantia nigra pars compacta (SNpc). Therefore, we engineered TRAP transgenic mice that enable
the easy, cell type-specific molecular profiling of DA neurons in the midbrain. Using these mice
under experimental conditions resembling PD, we generated translational libraries reflecting the
molecular signature of the DA neurons at an early stage of degeneration. For the characterization of
these libraries, we applied a systems biology approach going beyond differential gene expression
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analysis. This approach included the accurate assembly (reverse engineering) and interrogation of
a mouse brain regulatory network, which comprises a comprehensive repertoire of molecular in-
teractions between transcriptional regulators and their target genes. Our analysis revealed a set of
intrinsic upstream regulators that mediate the transcriptional response of midbrain DA neurons to
a toxic insult triggering degeneration. To validate our data, we applied both expression and func-
tional analyses using a virus-mediated knockdown strategy in DA neurons in vivo. We identified
transcriptional regulators that are highly and specifically expressed in unperturbed SNpc DA neu-
rons. The loss of these regulators is associated with DA neuron degeneration. Our approach can
be applied to other neurodegenerative disorders to discover novel molecular targets for therapeutic
intervention.
5.2 Results
A more detailed description of the experimental validation can be found in the manuscript version
of this chapter [Brichta et al., 2015].
5.2.1 Generation of TRAP transgenic mice for the cell type-specific profiling
of DA neurons and Characterization of Dat bacTRAP mice
Similar to other types of neurons in the CNS, DA neurons in the midbrain are intermixed with vari-
ous different neuronal and non-neuronal cells, including gamma-aminobutyric acid (GABA)-ergic
neurons, glutamatergic neurons, glial cells and endothelial cells. Thus, to optimize the cell type-
specific molecular profiling of DA neurons, we developed a strategy based on TRAP[Heiman et al.,
2008; Doyle et al., 2008]. Experimental validation showed that Dat bacTRAP mice facilitate the
enrichment of translated mRNAs specifically expressed by DA neurons. In contrast, transcripts that
are typically expressed by non-DA cells were enriched in the whole midbrain total RNA samples
and depleted from the DA neuron TRAP samples.
Analysis of the brain morphology, body composition, food, water intake of Dat bacTRAP mice
compared to normal mice demonstrated that the EGFP-L10a transgene did not cause any measur-
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able alterations of the morphological, stereological or biochemical characteristics of the midbrain
DA neurons in Dat bacTRAP mice. Further details of the procedures used can be found in the
manuscript version of this chapter [Brichta et al., 2015].
5.2.2 Translational profiling of midbrain DA neurons in a model of PD
After demonstrating the utility of Dat bacTRAP mice for the isolation of translated mRNAs from
midbrain DA neurons, we next applied the methodology to the molecular profiling of DA neu-
rons in a MPTP-induced mouse model of PD. MPTP is a toxin that specifically targets DA neu-
rons in both humans and mice and reproduces the degeneration of SNpc DA neurons associ-
ated with PD[Dauer and Przedborski, 2003]. The MPTP mouse model is extremely well estab-
lished, and widely considered the most suitable available mouse model to investigate the molecular
mechanisms that are involved in DA neuron degeneration[Jackson-Lewis and Przedborski, 2007;
Jackson-Lewis et al., 2012]
To carry out cell type-specific translational profiling of midbrain DA neurons, a second group
of Dat bacTRAP mice was injected with saline (vehicle) or MPTP following the subacute dosing
regimen. In contrast to the experimental concept used for the validation of MPTP potency, Dat
bacTRAP mice designated for translational profiling and expression analysis by RNA sequencing
(TRAPseq) were sacrificed four days after the last MPTP injection (Fig5.1). At this time point, the
number of SNpc DA neurons that are still viable but poised to die is maximal[Vila et al., 2001].
We reasoned that this strategy would allow us to profile SNpc DA neurons under stress at a very
early stage of degeneration rather than carrying out translational profiling at a stage mimicking ad-
vanced PD. Analysis of the cell type-specific translatome libraries reflecting the molecular profiles
either of unperturbed midbrain DA neurons in saline-treated Dat bacTRAP mice or of DA neurons
under toxin-induced stress in MPTP-treated Dat bacTRAP mice revealed a number of genes with
significantly different expression between both groups (Fig5.2).
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5.2.3 Identification of upstream transcriptional regulators of neurodegener-
ation
Numerous attempts to elucidate the molecular determinants underlying progressive cell loss in
neurodegenerative disorders have exclusively relied on the comparison of gene expression levels
in normal and pathological tissue. Unfortunately, this approach typically does not go beyond the
generation of comprehensive lists of differentially expressed genes which are ranked based on
the fold change of their transcript levels. In particular, the discovery of key upstream regulators
that cause the observed gene expression changes is not supported by this analysis. An innovative
systems biology approach to identify molecular targets for disease therapy has recently been de-
scribed in the field of cancer research[Piovan et al., 2013; Lefebvre et al., 2010; Carro et al., 2010;
Aytes et al., 2014]. In a first step, a tissue-specific network that maps relationships between down-
stream target genes and their upstream transcriptional regulators was computationally generated
using the ARACNe algorithm[Margolin et al., 2006]. This step was followed by the interrogation of
the engineered network with genome-wide expression signatures obtained from control and cancer
tissues: for each transcriptional regulator included in the network, the mapped downstream target
genes were tested for differential expression in cancer tissue. Thus, each set of downstream target
genes represents a comprehensive gene reporter assay for activity changes of the corresponding up-
stream transcriptional regulator. Transcriptional regulators that drive the gene expression signature
in cancer tissue were identified by the significant enrichment of differentially expressed, mapped
target genes. These regulators are termed Master Regulators (MRs), and the analysis is referred to
as MAster Regulator INference Algorithm (MARINa).
The basic principles of MARINa are not limited to the investigation of particular tumor types,
and have also shown promise for the discovery of disease determinants in non-cancerous conditions[Chen
et al., 2014; Repunte-Canonigo et al., 2015; ?]. Thus, we hypothesized that the application of this
methodology to the analysis of our cell type-specific DA neuron translatome libraries would fa-
cilitate the discovery of novel genes that determine DA neurodegeneration. We reverse engineered
a regulatory network from a mouse whole brain expression dataset consisting of 437 tissue sam-
ples (GSE10415) using ARACNe. The resulting adult mouse brain regulatory network contained
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338,550 interactions between 1,345 transcriptional regulators and 16,527 target genes. Next, using
the genome-wide translatome signatures we had obtained for unperturbed midbrain DA neurons
in saline-treated Dat bacTRAP mice or for DA neurons in MPTP-treated Dat bacTRAP mice, we
interrogated the mouse whole brain regulatory network to identify key transcriptional regulatory
proteins that mediate the response of DA neurons to degenerative stress. MARINa analysis identi-
fied 19 MR candidates that drive the molecular signature of midbrain DA neurons at a very early
stage of degeneration (Fig5.3). Ten MRs aberrantly increased their regulatory activity after the
challenge with MPTP. The remaining nine MRs decreased their activity.
We then investigated the translated mRNA levels of the 19 identified MR candidates in DA neu-
ron TRAP samples from mice that received either saline (vehicle) or MPTP. This analysis revealed
that the changes in MR transcriptional activity between saline and MPTP samples (Fig5.3) were
not associated with differential MR gene expression, suggesting that post-translational regulation
of the MRs is likely responsible for their altered transcriptional activities. Our findings are consis-
tent with the results obtained in several cancer phenotypes[Piovan et al., 2013; Carro et al., 2010;
Aytes et al., 2014] and show that these MRs could not have been identified by conventional means
relying exclusively on the examination of fold differences in transcript levels
5.2.4 Subtype-specific profiling of SNpc and VTA DA neurons
Discovery of the 19 MR candidates (Fig5.3) was based on the analysis of TRAP data obtained
from both SNpc and VTA DA neurons. SNpc DA neurons are more vulnerable to degeneration
in PD than VTA DA neurons. Therefore, to gain insight into the molecular alterations that are
specific to the response of SNpc DA neurons to degenerative stress, we were especially interested
in identifying MR candidates with higher baseline gene expression levels in SNpc DA neurons
which may point to a specific physiological relevance of these MRs for the SNpc. Dr. Lars Brichta
from the Greengard lab at Rockefeller University was responsible for these experiments.
To compare the baseline expression levels of the 19 MR candidates in SNpc and VTA DA
neurons, we dissected and separated the SNpc and VTA from Dat bacTRAP mice and carried out
TRAPseq. This analysis revealed that two of the MR candidates were more highly expressed in
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SNpc DA neurons than in VTA DA neurons, including DNA-binding protein Satb1 (Satb1, 1.6-
fold) and palmitoyltransferase Zdhhc2 (Zdhhc2, 1.8-fold).
Our results led us to conclude that unperturbed SNpc DA neurons in particular are characterized
by the high expression of SATB1 and ZDHHC2. Together with the findings from our regulatory
network analysis, which suggested that the regulatory activities of SATB1 and ZDHHC2 are re-
duced in DA neurons at an early stage of degeneration, we reasoned that SATB1 and ZDHHC2
represent intrinsic DA neuron pro-survival factors whose loss of function is associated with DA
cell death.
Importantly, congruent with Satb1 and Zdhhc2 mRNA quantification in mice that received
either saline or MPTP, Western blot analysis demonstrated that the altered transcriptional activities
of SATB1 and ZDHHC2 four days after MPTP treatment were not associated with changes in
the protein levels of these two MRs. This further validated that SATB1 and ZDHHC2 could not
have been identified using conventional expression analyses and that the MR activity changes are
due to the posttranslational regulation of these proteins in the DA neurons. Further details of the
procedures used can be found in the manuscript version of this chapter [Brichta et al., 2015].
5.2.5 Validation of novel determinants of SNpc DA neuron degeneration
A recent investigation in developing cortical interneurons in mice reported that the knockout of
SATB1 interferes with the migration, differentiation, connectivity and survival of these cells[Close
et al., 2012]. These findings supported our results which indicated that SATB1 represents a pro-
survival factor in mature DA neurons. However, to validate the role of SATB1 and ZDHHC2 in
SNpc DA neurons, and to demonstrate that our methodology consisting of translatome and regula-
tory network analysis is a powerful approach for the identification of key determinants involved in
neuronal degeneration, we investigated the consequences of SATB1 or ZDHHC2 knockdown on
the survival of DA neurons.
Knockdown of SATB1 mimicked the effect of MPTP, causing a 79.5±6.8% (mean±SEM) re-
duction in the number of SNpc TH+ neurons as compared to the SNpc that was injected with
the control vector. To provide biochemical evidence that the target genes identified by ARACNE
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(Fig5.3) are indeed regulated by the respective MR, we injected Dat bacTRAP mice and ana-
lyzed knockdown and control samples by TRAPseq early in the course of DA neurodegeneration.
Satb1 mRNA levels in knockdown samples were reduced to 33±10% (mean±SEM) compared to
controls. Using Gene Set Enrichment Analysis (GSEA), ARACNE-identified SATB1 target genes
were ranked according to their differential expression between knockdown and control samples.
Genes with the highest expression increase in the knockdown samples are displayed furthest to
the left in the plot, while genes with the greatest reduction of expression are displayed furthest to
the right. Strikingly, Satb1 silencing was associated with decreased SATB1 activity (indicated by
a negative NES) and the significant enrichment of downregulated SATB1 target genes (Fig5.4),
recapitulating the results obtained in MPTP-injected mice.
Experiments with the knockdown of Zdhhc2 knockdown of ZDHHC2 led to a 96.6±0.6%
(mean±SEM) reduction in the number of SNpc TH+ neurons as compared to the SNpc injected
with the scrambled shRNA vector. This finding suggested that non-DA neurons are affected by the
ZDHHC2 knockdown, which may be related to the observation of a signal for ZDHHC2 in the
unperturbed SNpc that did not co-localize with TH. Further details of the experimental results can
be found in the manuscript version of this chapter [Brichta et al., 2015]
To further validate our findings, we investigated whether SATB1 and ZDHHC2 could be identi-
fied as MRs of human DA neuron pathology at an early stage of Parkinson’s disease comparable to
the time point we chose for the TRAPseq analysis in the MPTP mouse model (Fig. ??). Therefore,
we carried out a regulatory network analysis on expression profiles obtained from substantia nigra
samples from human subjects with incipient Parkinson’s disease and from controls [Zheng et al.,
2010]. Strikingly, this analysis confirmed the significantly decreased transcriptional activities of
SATB1 and ZDHHC2 in those with incipient Parkinson’s disease (Fig. ??). Consistent with our
data obtained in mice, these changes were not associated with changes in the expression levels of
SATB1 and ZDHHC2 (Fig. ??).
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5.3 Discussion
Cell type-specific translational profiling of distinct groups of degenerating neurons in combination
with the analysis of a context-specific regulatory network is a novel, powerful approach to iden-
tify intrinsic molecular factors that drive neuronal loss. As part of this strategy, the generation and
application of suitable TRAP mouse lines enables the comprehensive analysis of neurons at any
desired degenerative stage in animal models of human disorders, including the very early stages.
Such studies overcome the impossibility of investigating the early stages of neurodegeneration in
humans and therefore provide an opportunity for the discovery of early molecular markers of the
disease process. Similarly, the application of a context-specific regulatory network for the analysis
of neuronal gene expression signatures is not limited to a certain stage of degeneration. The assem-
bled regulatory network represents a map of relationships between upstream transcriptional regula-
tors and their downstream target genes which is suitable for the analysis of the molecular signatures
of neurons independent of their pathological phenotype. The most significant technical advantage
provided by regulatory network analysis is the identification of neuron-intrinsic transcriptional reg-
ulators that are effectors of the recorded gene expression differences. Thus, the characterization of
hundreds of differentially expressed genes one by one is replaced by the discovery of respective
upstream regulators of these genes, whereby each regulator induces many of the measured changes
in downstream target gene expression.
5.3.1 Brain regulatory network analysis and identification of MRs
Our adult mouse brain regulatory network included 1,345 transcriptional regulators, and inves-
tigation of the DA neuron-specific translatome libraries facilitated the identification of 19 novel
MRs of early DA neuron degeneration. The analysis presented a completely unbiased approach
that equally considers the involvement of each of the 1,345 transcriptional regulators included
in the brain regulatory network. Importantly, the expression levels of the MRs identified in our
study remained unchanged and did not account for the toxin-induced changes in MR activity. Post-
translational modifications of the MR proteins may be responsible for this observation. Therefore,
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our combinatorial approach consisting of translatome and regulatory network analysis not only
enabled the discovery of novel key determinants of neurodegeneration, but also facilitated the
identification of those genes that cannot be detected exclusively by comparing gene expression
levels. The comparative TRAPseq analysis of SNpc and VTA DA neurons provided a useful data
resource for translated mRNAs that are enriched in either of the two cell types, which may facili-
tate the discovery of genes with a potential role in differential DA neuron vulnerability. Expression
analysis of the 19 identified MR candidates in SNpc and VTA DA neurons revealed that SATB1
and ZDHHC2 are highly expressed in SNpc DA neurons, pointing to a function of these two pro-
teins specifically in these cells. Interestingly, eight MR candidates were more highly expressed
in VTA DA neurons than in SNpc DA neurons, and several of these regulators increased their
activity after the challenge of midbrain DA neurons with MPTP. These findings may indicate a
connection between the elevated activity of these MRs and the decreased vulnerability of VTA DA
neurons to degeneration, warranting further investigation. The group of MRs with similar expres-
sion levels in SNpc and VTA DA neurons included myocyte-specific enhancer factor (MEF) 2A
and methyl-CpG-binding protein 2 (MECP2), both of which decreased their regulatory activity in
DA neurons under MPTP induced stress. A recent investigation reported the reduced transcrip-
tional activity of another MEF2 isoform, MEF2C, in a human stem cell-derived DA neuron model
of PD while the protein levels of MEF2 did not change[Ryan et al., 2013]. MEF2C plays an im-
portant role in DA neurogenesis and differentiation in embryonic stem cells[Okamoto et al., 2000;
Cho et al., 2011]. However, in murine adult SNpc DA neurons in vivo, Mef2a expression lev-
els (Fig ??e) are much higher than those of Mef2c (FPKM<1), which suggests that the two
isoforms possibly fulfill similar functions in the two model systems. Studies in mutant MECP2
mice have demonstrated alterations in the survival and function of DA neurons[Gantz et al., 2011;
Panayotis et al., 2011]. In agreement with a pro-survival function of MECP2 in DA neurons, our
translatome-regulatory network analysis found a decreased activity for MECP2 in degenerating
DA neurons, which further demonstrated the validity of our methodology.
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5.3.2 Validation of novel drivers of DA degeneration
SATB1 and ZDHHC2 represent two novel endogenous neuroprotective proteins which may have
evolved as a protective mechanism for the highly vulnerable SNpc DA neurons. The enrichment
of SATB1 and ZDHHC2 in adult SNpc DA neurons appears to reflect an intrinsic defense mech-
anism that opposes neurodegeneration. Both proteins are required to maintain the DA phenotype,
and the disruption of their function is sufficient to induce DA neuron degeneration. The concept of
protective factors being highly expressed in the vulnerable SNpc DA neurons is in contrast to the
traditional hypothesis that protective genes are expressed particularly in the more resistant VTA
DA neurons. However, it has been demonstrated that SNpc DA neurons are under tonic cellular
stress[Chan et al., 2007; Guzman et al., 2010; Mosharov et al., 2009], which may explain the ele-
vated need for intrinsic protection as compared to VTA DA neurons. Disruption of essential SNpc-
specific protective mechanisms is likely to result in rapid cell death. SATB1 is a transcriptional
regulator and DNA organizer[Yasui et al., 2002], and in agreement with this function, its cellular
localization is restricted to the nucleus. In contrast, we detected ZDHHC2 in the Golgi apparatus
of DA neurons. Based on this observation, it seems unlikely that ZDHHC2 directly regulates the
expression of its target genes. However, ZDHHC2 is able to palmitoylate other proteins[Roth et al.,
2006] which can result in the modulation of protein-protein interactions, thus eventually altering
transcription[Kostiuk et al., 2010].
Complementary to the observation that MPTP causes a decrease in SATB1 and ZDHHC2 activ-
ity but not in SATB1 and ZDHHC2 expression levels, viral overexpression of wildtype SATB1 or
ZDHHC2 had no effect on MPTP-induced neurodegeneration. Hypothesizing that MPTP interferes
with the post-translational modification of SATB1 and ZDHHC2, overexpression of constitutively
active mutant versions of these proteins is necessary to evaluate if they can protect against DA neu-
ron degeneration. Such studies would require the identification of all of the post-translational mod-
ifications that regulate the transcriptional activity of SATB1 and ZDHHC2 in SNpc DA neurons.
In this context, it would also be of interest to search for candidate modulators of MR activity by
applying algorithms such as MINDy[Wang et al., 2009]. Moreover, the DIGGIT algorithm[Chen
et al., 2014] can facilitate the integration of genetic information provided by GWAS studies with
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regulatory transcriptional and post-transcriptional models of cellular control. This approach may
be instrumental in elucidating causal genetic determinants predisposing to disease. However, this
analysis would not facilitate the identification of the actual target sites of the post-translational
modifications that impact the transcriptional activity of SATB1 and ZDHHC2.
The identification and validation of SATB1 and ZDHHC2 clearly demonstrates that our strat-
egy consisting of translational profiling of degenerating neurons and the analysis of a context-
specific brain regulatory network can successfully be applied to the discovery of novel determi-
nants of neuronal loss. Importantly, we confirmed the decreased activities of SATB1 and ZDHHC2
in samples from patients with incipient PD. Based on the present investigations, it appears feasi-
ble to apply a similar strategy to the characterization of distinct groups of degenerating neurons in
models of various disorders other than PD, including Alzheimer’s disease, spinal muscular atrophy,
Huntington’s disease and amyotrophic lateral sclerosis.
5.4 Methods
5.4.1 TRAPseq and gene expression analysis
To compose MPTP and vehicle translatome libraries, RNA-Seq reads were first mapped to the Mus
musculus assembly nine reference genome using Bowtie[Langmead et al., 2009]. Reads mapping
to known genes, based on Entrez gene identifiers, were then counted using the GenomicFeatures
R-system package (Bioconductor)[Gentleman et al., 2004]. Differential expression was calculated
using DESeq version 1.20.0 and R version 3.1.1. For all other RNA-Seq analyses, reads were
mapped to the Mus musculus assembly 10 reference genome using TopHat[Trapnell et al., 2009a]
version 2.0.11. FPKM values for all genes in each sample were calculated with Cufflinks[Trapnell
et al., 2010] version 2.2.1. To analyze differential gene expression between samples, DESeq[An-
ders and Huber, 2010] version 1.14.0 was used under the standard comparison mode. P values were
reported by DESeq, adjusted for multiple testing using the Benjamini-Hochberg procedure.
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5.4.2 Regulatory networks assembly
The regulatory network was reverse engineered from a phenotypically diverse mouse brain expres-
sion dataset obtained from seven brain regions (hippocampus, cerebellum, olfactory bulb, basal
ganglia, frontal cortex, cingulate cortex, amygdala) from six- to eight-week-old laboratory mice
belonging to 20 different inbred strains (437 samples, GSE10415) using ARACNe[Margolin et al.,
2006]. ARACNe was run with 100 bootstrap iterations using all probes that mapped to a set of
1,507 mouse transcriptional regulators which were defined as genes annotated as GO:0003700 -
‘transcription factor activity’ in the Gene Ontology Molecular Function database[Ashburner et al.,
2000]. Parameters were set to 0 DPI tolerance and a MI P value threshold (P< 10−7), as rec-
ommended for bootstrap ARACNe analysis of a dataset with this size, to achieve a Bonferroni
corrected significance (P = 0.05) for getting a single false-positive in the dataset. The regulatory
network used in our study is available for download from figshare http://dx.doi.org/10.
6084/m9.figshare.926507.
5.4.3 MR analyses on mouse translatomes
To define the MPTP-specific genome-wide expression signature for midbrain DA neurons, we
composed a list of all genes, arranged from the gene with the most down-regulated expression
in response to MPTP to the gene with the most up-regulated expression. Differential expression
was computed by comparing MPTP and saline (vehicle) samples using Student’s t-test after nor-
malizing the raw counts by a negative binomial-based variance stabilizing transformation (VST)
implemented in the DESeq package (Bioconductor). MRs were obtained from the MPTP-specific
signature using the MARINa algorithm together with the mouse whole brain regulatory network
[Lefebvre et al., 2010; Carro et al., 2010]. The MARINa algorithm used in our studies is an im-
proved version of the original algorithm[Lefebvre et al., 2010; Carro et al., 2010] with the follow-
ing modifications:
1. It tests for a global shift in the position of the regulons when projected on the gene expression
signature instead of using the Kolmorogov-Smirnov test statistics
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2. It uses a probabilistic framework to integrate knowledge of activated, repressed, and non-
monotonically regulated transcriptional targets
3. it takes into account pleiotropic regulation of each target gene by multiple regulators when
computing the enrichment.
Statistical significance, including P value and normalized enrichment score (NES), was esti-
mated by comparison to a null model generated by permuting the samples uniformly at random
1,000 times. The MARINa algorithm is implemented in the ssMARINA R-package and available
for download from figshare (http://dx.doi.org/10.6084/m9.figshare.785718).
The results of the MR analysis have been recorded as a Sweave document, which is designed to
outline the set-up and running of MARINa on the saline- and MPTP-specific translatomes. When
compiled, the document will run the computational analysis described in the manuscript and output
the results as a table and plot (corresponding to Fig??d).
5.4.4 MR analysis on PD expression signatures
Analysis was carried out on a dataset obtained from SN samples from 16 cases with incipient PD
and 17 controls (Gene Expression Omnibus accession #GSE20159)[Zheng et al., 2010]. Data was
downloaded and converted into Entrez Gene IDs to allow for the comparison with the human-
ized mouse brain regulatory network. For genes that mapped to multiple probesets, the probeset
with the highest coefficient of variation was used. MARINa was run using the predictions of the
mouse brain regulatory network converted to homologous human Entrez Gene IDs using a database
from the Mouse Genome Informatics (MGI) website (http://www.informatics.jax.
org/). Incipient PD samples were compared with control samples by Student’s t-test and signifi-
cance was assessed using 10,000 gene label-shuffling randomizations with the Bonferroni method
used for multiple hypothesis correction. The humanized mouse brain regulatory network used in




Gene Set Enrichment Analysis was performed as described[Subramanian et al., 2005] using an
in-house implementation in R 3.0.1. Statistical significance was estimated by comparison to a null
model generated by permuting the gene labels uniformly at random 10,000 times. The datasets
used for GSEA analysis of SATB1 target genes on differentially expressed genes between SATB1
control and SATB1 knockdown TRAP samples are available for download from figshare (http:
//dx.doi.org/10.6084/m9.figshare.926518).
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Figure 5.1: Generation of Dat bacTRAP mice for the translational profiling of midbrain DA
neurons.Timeline for TRAPseq analysis of midbrain DA neurons after injection of Dat bacTRAP
mice with MPTP (n = 4) or saline (vehicle; n = 4).
152
Figure 5.2: Comparative analysis of the MPTP-treated translatomeComparative analysis of the
translatome libraries obtained from unperturbed midbrain DA neurons in saline-treated Dat bac-
TRAP mice (n = 4) or from DA neurons under toxin-induced stress in MPTP-treated Dat bacTRAP
mice (n = 4). Log2 fold change values were plotted against mean gene expression values. The cen-
ter line represents equal expression. Green dots represent transcripts with a ≥ 1.5-fold increased
expression in MPTP-treated samples (P < 0.05). Red dots represent transcripts with a ≥1.5-fold
decreased expression in MPTP-treated samples (P < 0.05). Black dots represent nonsignificant
transcripts.
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Figure 5.3: Results of MARINa AnalysisStatistically significant MRs (P < 0.01) determined by
MARINa analysis for the MPTP-specific translatome signature. Each row of the plot shows the
MARINa results obtained for the respective MR. The heat map on the right shows the predicted
MR activity, with red indicating an increase of activity in MPTP-treated samples (corresponding
to a positive normalized enrichment score (NES)) and blue indicating a decrease (corresponding
to a negative NES). NES values were calculated by MARINa. The x axis represents the MPTP-
specific translatome signature, arranged from the gene with the greatest decrease in expression to
the gene with the greatest increase in expression, compared to control. The vertical red and blue
lines correspond to ARACNe-predicted target genes of the respective MR. Positively regulated
target genes (expression induced by the MR) are shown in red. Negatively regulated target genes
(expression repressed by the MR) are shown in blue. Increased activity of an MR is indicated
by the significant enrichment of its positive targets among the upregulated genes in the MPTP
translatome signature and of its negative targets among the downregulated genes in the MPTP
translatome signature. Conversely, decreased MR activity is indicated by the significant enrichment
of its positive targets among the downregulated genes in the MPTP translatome signature and of
its negative targets among the upregulated genes in the MPTP translatome signature.
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Figure 5.4: Virus-mediated knockdown of SATB1 in SNpc DA neurons GSEA of SATB1 target
genes (vertical bars) on a ranked list of genes differentially expressed after Satb1 silencing in Dat
bacTRAP mice according to (a) (n=3; biological replicates), sorted by their t-statistics. Genes that
are downregulated after Satb1 silencing received high rank numbers and are displayed in the right






Through my dissertation, I was able to show that systems-level analysis using reverse-engineered
regulatory networks was a very effective tool for allowing an unprecedented view into the mech-
anisms underlying complex processes like cell-fusion mediated reprogramming, as well as CNS
disorders like Alcohol Addiction, and neurodegenerative disorders like Alzheimer’s Disease (AD),
and Parkinson’s Disease (PD). The methods allowed for the modeling of these complex diseases
and physiological effects as modules of genes and transcription factors (TFs) that are causally
associated with the transition into the disease or developmental phenotype.
My work in heterokaryons is one of the first demonstrations of the combination of bispecies
heterokaryons, transcriptome profiling and regulatory network analysis in the study of this con-
text, and offers an unprecedented view of the early events of cell-fusion mediated reprogramming.
The computational findings suggest that reprogramming occurs through the activation of two tran-
scriptional programs that are activated in a bimodal manner, which then drive the B cell up the
hematopoietic differentiation hierarchy. The application of SVD analysis to the predictions of the
transcriptional network allowed us to determine that these two programs account for the majority
of total transcriptional activity during the reprogramming process. The computational predictions
are being further validated in vitro and in vivo, and will allow for a much more complete under-
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standing of the mechanisms underlying the reprogramming process. If successfully validated ex-
perimentally, the results would be one of the first demonstrations of reprogramming human B-cells
into HSCs and progenitors, and would have significant therapeutic implications. One major chal-
lenge associated with the allogeneic transplantation of HLA-matched HSCs is graft rejection [Lee
et al., 2015]. Being able to generate HSCs by differentiating iPS cells to hematopoietic progenitors
could serve as a valuable tool for the generation of HSCs and would allow for safer autologous
transplantation therapies.
The successful application of regulatory network analysis to the prediction of causal regulators
of neurological disorders like Alcohol Addiction, Alzheimer’s Disease and Parkinson’s Disease are
also notable, especially since information-theoretic methods like ARACNe, MARINa and VIPER
were originally developed and validated in contexts that were relatively close to equilibrium, such
as cancer cells [Lefebvre et al., 2012]. The extension of the methods into contexts that were as-
sociated with rapid changes in the cell at the activity and neurotransmitter level were certainly
not trivial. In addition to the predictive power of these methodologies, which extended far beyond
their original contexts, the projects also benefited from a careful selection of the data, as well as
the system being studied.
In the case of Alcohol Addiction, our work focused on an animal model which described the
long-term gene expression changes that are associated with chronic alcohol addiction. By using an
animal model focused on the long-term, rather than acute changes associated with alcohol addic-
tion, and by considering brain regions that were known sites of drug action, we were able to study
a very specific aspect of the complex disease. In essence, we were able to “peel-back” one of the
layers of the complex disease and investigate it exclusively. As a result, we were able to construct
a robust network that provided functional evidence for a role of Nr3c1 and a novel transcriptional
activator (Psip1) in excessive drinking in alcohol-dependent rats. In the future, a similar approach
could hold much promise in the study of alcoholism in humans, and could reveal novel therapeutic
targets for treatment.
In the case of neurodegenerative disorders, our work benefited greatly from the additional con-
text specificity that we were able to achieve in the generation of the network and signatures. For
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Alzheimer’s disease, the samples were generated using through laser capture microdissection of
the neurons from brain regions that were progressively affected by the disorder. This ensured that
both the network and signatures were neuron-specific, rather than being a combination of neuron
and glial samples. Through the application the regulatory network based approaches to the data,
and by comparing control with intermediate and late-state AD samples, we were able to achieve
a dynamic interpretation of the static postmortem state. This addresses a significant challenge as-
sociated with studying AD, in which current animal models do not replicate the full pathological
picture and are therefore of limited usage for biochemical studies and drug discovery.
In the study of PD, the use of the bac-TRAP technique allowed for an even more specific profil-
ing of neurons, allowing us to exclusively measure the expression changes of genes that were being
actively translated in dopaminergic neurons in the SNpc. This specificity allowed for the identifica-
tion of two neuroprotective factors that were specific to SNpc dopaminergic neurons. In addition,
we were able to confirm the activities of SATB1 and ZDHHC2 in human subjects with incipient
Parkinson’s disease, which provides added evidence that the application of a similar strategy will
provide added insights to the characterization of distinct groups of degenerating neurons in mod-
els of disorders other than Parkinson’s disease, including spinal muscular atrophy, Huntington’s
disease and amyotrophic lateral sclerosis.
As further work, a similar methodology may be applied to a complementary ‘layer’ of neu-
rodegenerative disorders, namely transcriptional changes in the microglia and astrocytes, and the
investigation of their role in AD, PD and other diseases. With the development of datasets that in-
clude separate transcriptional characterizations of these different types of cells [Cahoy et al., 2008;
Zhang et al., 2014], the time may be ripe for the investigation of contributions of microglia and
astrocytes to these disorders at a network level. This would provide additional insights into the
dysregulation associated with the progression of these disorders, and would provide yet another
layer toward our understanding of these diseases.
In that way, we may be able to continue to integrate different ‘layers’ of complex diseases,
each providing a specific, but partial picture of the disorder, and combine them toward a perfect
and complete understanding of development, neurodegeneration, and addiction.
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Koster, J., Coffer, P. J., Pals, S. T., and Spaargaren, M. (2014). Foxp1 directly represses tran-
scription of proapoptotic genes and cooperates with nf-κb to promote survival of human b cells.
Blood, 124(23):3431–3440.
[Vendruscolo et al., 2012] Vendruscolo, L. F., Barbier, E., Schlosburg, J. E., Misra, K. K., Whit-
field, T. W., Logrip, M. L., Rivier, C., Repunte-Canonigo, V., Zorrilla, E. P., Sanna, P. P., et al.
(2012). Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. The
Journal of Neuroscience, 32(22):7563–7571.
[Vendruscolo and Roberts, 2013] Vendruscolo, L. F. and Roberts, A. J. (2013). Operant alcohol
self-administration in dependent rats: Focus on the vapor model. Alcohol.
[Vila et al., 2001] Vila, M., Jackson-Lewis, V., Vukosavic, S., Djaldetti, R., Liberatore, G., Offen,
D., Korsmeyer, S. J., and Przedborski, S. (2001). Bax ablation prevents dopaminergic neurode-
generation in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson’s
disease. Proc Natl Acad Sci U S A, 98(5):2837–42.
[Vlotides et al., 2007] Vlotides, G., Eigler, T., and Melmed, S. (2007). Pituitary tumor-
transforming gene: physiology and implications for tumorigenesis. Endocrine reviews,
28(2):165–186.
[Wang et al., 2009] Wang, K., Saito, M., Bisikirska, B. C., Alvarez, M. J., Lim, W. K., Rajbhan-
dari, P., Shen, Q., Nemenman, I., Basso, K., Margolin, A. A., et al. (2009). Genome-wide
identification of post-translational modulators of transcription factor activity in human b cells.
Nature biotechnology, 27(9):829–837.
181
[Wang et al., 2003] Wang, X., Willenbring, H., Akkari, Y., Torimaru, Y., Foster, M., Al-Dhalimy,
M., Lagasse, E., Finegold, M., Olson, S., and Grompe, M. (2003). Cell fusion is the principal
source of bone-marrow-derived hepatocytes. Nature, 422(6934):897–901.
[WHO, 2011] WHO (2011). Global health and aging.
[Wilson et al., 1999] Wilson, C. A., Doms, R. W., and Lee, V. M. (1999). Intracellular app pro-
cessing and a beta production in alzheimer disease. J Neuropathol Exp Neurol, 58(8):787–94.
[Wingender et al., 2000] Wingender, E., Chen, X., Hehl, R., Karas, H., Liebich, I., Matys, V.,
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